<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Biol</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Biol</journal-id>
    <journal-title-group>
      <journal-title>BMC Biology</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1741-7007</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9281121</article-id>
    <article-id pub-id-type="publisher-id">1364</article-id>
    <article-id pub-id-type="doi">10.1186/s12915-022-01364-6</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Systematic prediction of degrons and E3 ubiquitin ligase binding via deep learning</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Hou</surname>
          <given-names>Chao</given-names>
        </name>
        <address>
          <email>hou_chao@pku.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Li</surname>
          <given-names>Yuxuan</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Mengyao</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wu</surname>
          <given-names>Hong</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff5">5</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4266-0317</contrib-id>
        <name>
          <surname>Li</surname>
          <given-names>Tingting</given-names>
        </name>
        <address>
          <email>litt@hsc.pku.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.11135.37</institution-id><institution-id institution-id-type="ISNI">0000 0001 2256 9319</institution-id><institution>Department of Biomedical Informatics, School of Basic Medical Sciences, </institution><institution>Peking University Health Science Center, </institution></institution-wrap>Beijing, 100191 China </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.11135.37</institution-id><institution-id institution-id-type="ISNI">0000 0001 2256 9319</institution-id><institution>Key Laboratory for Neuroscience, Ministry of Education/National Health Commission of China, Peking University, </institution></institution-wrap>Beijing, 100191 China </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.11135.37</institution-id><institution-id institution-id-type="ISNI">0000 0001 2256 9319</institution-id><institution>The MOE Key Laboratory of Cell Proliferation and Differentiation, School of Life Sciences, Peking University, </institution></institution-wrap>Beijing, 100871 China </aff>
      <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.452723.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 7887 9190</institution-id><institution>Peking-Tsinghua Center for Life Sciences, </institution></institution-wrap>Beijing, China </aff>
      <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.510951.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 7775 6738</institution-id><institution>Institute for Cancer Research, Shenzhen Bay Laboratory, </institution></institution-wrap>Shenzhen, China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>14</day>
      <month>7</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>14</day>
      <month>7</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2022</year>
    </pub-date>
    <volume>20</volume>
    <elocation-id>162</elocation-id>
    <history>
      <date date-type="received">
        <day>1</day>
        <month>3</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>29</day>
        <month>6</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Â© The Author(s) 2022</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">Degrons are short linear motifs, bound by E3 ubiquitin ligase to target protein substrates to be degraded by the ubiquitin-proteasome system. Mutations leading to deregulation of degron functionality disrupt control of protein abundance due to mistargeting of proteins destined for degradation and often result in pathologies. Targeting degrons by small molecules also emerges as an exciting drug design strategy to upregulate the expression of specific proteins. Despite their essential function and disease targetability, reliable identification of degrons remains a conundrum. Here, we developed a deep learning-based model named Degpred that predicts general degrons directly from protein sequences.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">We showed that the BERT-based model performed well in predicting degrons singly from protein sequences. Then, we used the deep learning model Degpred to predict degrons proteome-widely. Degpred successfully captured typical degron-related sequence properties and predicted degrons beyond those from motif-based methods which use a handful of E3 motifs to match possible degrons. Furthermore, we calculated E3 motifs using predicted degrons on the substrates in our collected E3-substrate interaction dataset and constructed a regulatory network of protein degradation by assigning predicted degrons to specific E3s with calculated motifs. Critically, we experimentally verified that a predicted SPOP binding degron on CBX6 prompts CBX6 degradation and mediates the interaction with SPOP. We also showed that the protein degradation regulatory system is important in tumorigenesis by surveying degron-related mutations in TCGA.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">Degpred provides an efficient tool to proteome-wide prediction of degrons and binding E3s singly from protein sequences. Degpred successfully captures typical degron-related sequence properties and predicts degrons beyond those from previously used motif-based methods, thus greatly expanding the degron landscape, which should advance the understanding of protein degradation, and allow exploration of uncharacterized alterations of proteins in diseases. To make it easier for readers to access collected and predicted datasets, we integrated these data into the website <ext-link ext-link-type="uri" xlink:href="http://degron.phasep.pro/">http://degron.phasep.pro/</ext-link>.</p>
      </sec>
      <sec>
        <title>Supplementary Information</title>
        <p>The online version contains supplementary material available at 10.1186/s12915-022-01364-6.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Degron</kwd>
      <kwd>E3 Ubiquitin ligase</kwd>
      <kwd>Protein degradation</kwd>
      <kwd>Deep learning</kwd>
      <kwd>Cancer driver mutation</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>National Key Research and Development Program of China</institution>
        </funding-source>
        <award-id>2018YFA0507504</award-id>
        <award-id>2021YFF1200900</award-id>
        <principal-award-recipient>
          <name>
            <surname>Li</surname>
            <given-names>Tingting</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id>
            <institution>National Natural Science Foundation of China</institution>
          </institution-wrap>
        </funding-source>
        <award-id>32070666</award-id>
        <award-id>61773025</award-id>
        <principal-award-recipient>
          <name>
            <surname>Li</surname>
            <given-names>Tingting</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>Â© The Author(s) 2022</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par24">The ubiquitin-proteasome system (UPS) dynamically regulates protein turnover in cell differentiation, cell cycle, and signaling pathways [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>], with over 80% of intracellular proteins being degraded via UPS [<xref ref-type="bibr" rid="CR3">3</xref>]. During the degradation process, ubiquitin (Ub) is covalently attached to lysine (K) on the substrate, which is catalyzed by E1 ubiquitin-activating enzymes, E2 ubiquitin-conjugating enzymes, and E3 ubiquitin ligases [<xref ref-type="bibr" rid="CR4">4</xref>]. Subsequently, the ubiquitinated substrate is transferred to and degraded by the 26S proteasome [<xref ref-type="bibr" rid="CR5">5</xref>]. The human genome encodes two E1s, 41 E2s, and more than 600 E3s [<xref ref-type="bibr" rid="CR6">6</xref>]. E3s bind their substrates directly via E3 binding sites present on the surface of substrates. These binding sites are called degrons [<xref ref-type="bibr" rid="CR7">7</xref>]. The interaction between E3 and degron determines the specificity of the degradation process.</p>
    <p id="Par25">Degrons are preferentially located in disordered regions and are molecular recognition features (MoRFs) that undergo disorder-to-order transition upon binding to E3s [<xref ref-type="bibr" rid="CR8">8</xref>]. Degrons are typically regulated by post-translational modifications (PTMs), which control the interaction with E3s in response to environmental and cellular cues [<xref ref-type="bibr" rid="CR9">9</xref>]. Degrons mediate the ubiquitination of substrates, and the resulting Ub-sites are usually located within 20 amino acids (AAs) distant from the degron [<xref ref-type="bibr" rid="CR7">7</xref>]. A fundamental property of degrons is their transferability: in most cases, transplantation of a degron to a protein accelerates the degradation of a protein [<xref ref-type="bibr" rid="CR10">10</xref>]. In contrast, dysfunction of degrons disturbs control of protein degradation and causes abnormally accumulating proteins, thus further contributing to pathological progression [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. This situation particularly applies to cancer, a disease that involves the enhanced expression of oncogenes. Recently, researchers explored the targetability of degrons by designing small molecules for a degron on tumor suppressor p53. Two resulting small molecules upregulated p53 expression and restored p53 function, which provide an opportunity to inhibit cancer cell growth [<xref ref-type="bibr" rid="CR12">12</xref>]. Thus, identifying degrons on the substrates should greatly assist in investigating the pathogenesis of related diseases and provide potential therapeutic targets.</p>
    <p id="Par26">Both low-throughput and high-throughput experimental approaches have been employed to identify degrons. Low-throughput identification of degrons usually require deletion or mutation of specific sites on proteins coupled with half-life experiments or co-immunoprecipitation with specific E3s [<xref ref-type="bibr" rid="CR13">13</xref>]. However, many degrons are exposed to E3s only when proteins fail to fold correctly [<xref ref-type="bibr" rid="CR14">14</xref>] and thus fail to interact with E3s or prompt degradation on well-folded proteins. In addition, the interactions between E3s and substrates are temporary [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Thus, low-throughput identification of degrons faces many challenges, and only a limited number of degrons have so far been identified [<xref ref-type="bibr" rid="CR16">16</xref>]. Recently, high-throughput methods were designed to identify degrons as well. These methods were based on the transferability of degrons [<xref ref-type="bibr" rid="CR14">14</xref>] and considered the peptides that promote the degradation of a reporter protein as degrons [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. For example, Elledge and colleagues developed a bimodal fluorescent expression cassette termed Global Protein Stability (GPS) to discover N-end and C-end degrons [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. However, this method did not identify internal degrons, and it is almost impossible to screen all peptides in the human proteome. Notably, flexible segments facilitating access to the catalytic core of proteasome and peptides prone to be ubiquitinated can also promote the degradation of the reporter protein [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. As a consequence, the destabilizing peptides identified via high-throughput methods may represent not only degrons but also other functional peptides that accelerate protein degradation [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Given the complexity and difficulty of experimental identification of degrons, an efficient predictor is urgently required to facilitate degron discovery.</p>
    <p id="Par27">However, only a few bioinformatic tools have been developed to predict possible degrons. Motif matching is widely used in predicting degrons, and 25 degron motifs from the ELM motif database are commonly used [<xref ref-type="bibr" rid="CR16">16</xref>]. While motif matching excels in predicting possible degrons fast from local sequence patterns, it fails to consider other critical features such as structure or solvent accessibility of specific sites, which leads to high false-positive rate of motif matches. To reduce the false-positive rate of motif matching, MartÃ­nez-JimÃ©nez et al. scored all internal motif matches in human proteome using a random forest classifier (hereafter Motif_RF) with 11 biochemical features, including flanking phosphorylation sites, disordered regions, MoRFs, solvent accessibility, conservation, secondary structure, and flanking ubiquitinated Ks [<xref ref-type="bibr" rid="CR20">20</xref>]. Motif_RF identified over 20,000 likely new degrons in different protein isoforms. Nevertheless, Motif_RF failed to predict terminal degrons and could not be applied to proteins without available PTM data. Besides, only less than 30 E3 motifs are available for motif-based methods, which cannot even cover degrons for 5% of more than 600 E3s, precluding us from identifying degrons bound by other E3s. Tokheim et al. trained a deep learning model deepDegron on high-throughput GPS data to predict N-end and C-end degrons [<xref ref-type="bibr" rid="CR11">11</xref>]. deepDegron can only predict terminal degrons, and its training set derived from GPS experiment not only includes degrons. Thus, the predicted results of deepDegron represent multiple destabilizing peptides. Overall, exiting degron predictors are limited by either a high false positive rate or a limited application range. A more general model is needed to give a broader and unbiased prediction of degrons.</p>
    <p id="Par28">Besides identifying degrons, identifying E3-substrate interactions (ESIs) is also an area of intense study. Experiments like co-immunoprecipitation, two-hybrid screening, and mass spectrometry are commonly used to discover new ESIs [<xref ref-type="bibr" rid="CR15">15</xref>]. Recently, machine learning-based ESI predictors were developed as well. Wang et al. developed Ubibrowser 2.0 [<xref ref-type="bibr" rid="CR21">21</xref>] to predict ESIs using the enriched domain, GO term pair, protein-protein interaction, and inferred E3 recognition consensus motif; Chen et al. [<xref ref-type="bibr" rid="CR22">22</xref>] built a machine learning model (hereafter ChenESI) to predict ESIs from proteomics data, transcriptomics data, protein-protein interaction, and pathway-based associations. However, both experimental methods and prediction methods lack binding degron information. Here, we solved this restriction by combining our degron predictor and E3 motifs.</p>
    <p id="Par29">In this work, we predict degrons using a BERT-based deep learning approach. Our newly designed model Degpred successfully captures degron-related sequence properties and considerably expands the degron landscape. By assigning predicted degrons to E3s using our generated E3 motifs, we predicted ESIs with binding degron information. We also investigated the significance of degrons and binding E3s in protein turnover and tumorigenesis.</p>
  </sec>
  <sec id="Sec2">
    <title>Results</title>
    <sec id="Sec3">
      <title>The BERT-based model predicts degrons of new sequence patterns</title>
      <p id="Par30">To train and evaluate models, we collected known degrons from ELM [<xref ref-type="bibr" rid="CR16">16</xref>] database and three previous studies [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR20">20</xref>] (Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>a). For the same degrons present on different isoforms of one gene, only main isoforms in UniProt [<xref ref-type="bibr" rid="CR23">23</xref>] were reserved. In total, 303 degrons typically spanned 5-10 AAs were obtained (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S1a, Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S1).<fig id="Fig1"><label>Fig. 1</label><caption><p>Degron collection, processing, and model performance. <bold>a</bold> Degrons were collected from the true positive degrons in the ELM database and three previous studies. Venn diagram showing the overlap of collected degrons from three previous studies. <bold>b</bold> Data augmentation: sampling 128AA-peptides around degrons from original protein sequences. The blue rectangles represent degrons, and the black lines represent peptide sequences. <bold>c</bold> Training sets, test sets, and performances of models, models were evaluated with the area under the receiver operating characteristic curve (AUC). <bold>d</bold> Degron clustering and composition of five clusters, Seqlogos in the upper panel show the sequence patterns of alignment cores for five clusters in Gibbscluster, classes accounting for at least 10 percent in each cluster are labeled in pie graphs</p></caption><graphic xlink:href="12915_2022_1364_Fig1_HTML" id="MO1"/></fig></p>
      <p id="Par31">Previous predictors predict degrons by integrating protein features like flanking phosphorylation sites, intrinsically disordered regions, MoRFs, solvent accessibility, and flanking ubiquitinated Ks [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. However, these models cannot be applied to proteins without PTM data, and annotating proteins with these features is time-consuming. Thus, we turned to using BERT-based deep learning models, which have been shown to successfully represent fundamental and advanced properties of proteins, including secondary structure, target binding sites, contact, and PTMs [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. We built a BERT-based model to predict degrons that consists of a pre-trained TAPE BERT-encoding model [<xref ref-type="bibr" rid="CR27">27</xref>], two bidirectional long short-term memory layers, and two fully connected layers. The architecture took a protein sequence as input and outputted scores for all AAs on the protein (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S1b, see <xref rid="Sec12" ref-type="sec">Methods</xref> for details).</p>
      <p id="Par32">To explore the feasibility of using the BERT-based model to predict degrons, we compared the ability of our model with Motif_RF and a general MoRF predictor MoRFchibi [<xref ref-type="bibr" rid="CR8">8</xref>] to classify degrons from motif matches. In the training and test stages, our collected degrons were labeled as 1, while randomly selected motif matches from proteins without known degrons were labeled as 0. We averaged predicted scores of AAs in degrons or negative motif matches to represent the score of the BERT-based model. The BERT-based model achieved comparable performance with Motif_RF under fivefold cross-validation, and both methods significantly outperformed MoRFchibi (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S1c, see <xref rid="Sec12" ref-type="sec">Methods</xref> for detail). This result indicated that the BERT-based model provides an alternative to protein feature integrating predictors. The advantage of the BERT-based model is that it only needs protein sequence as input and has broader scope of application.</p>
      <p id="Par33">As degrons derived from motifs only represent a small proportion of all degrons bound by more than 600 E3s, we next used our model to score all AAs in sequences rather than only AAs in motif matches of a limited number of motifs. To provide more inputs for the training of the deep learning model, we augmented known degrons by sampling peptides from original proteins. We randomly sampled ten peptides of 128 AAs containing the degron from the original protein for each degron, and generated 3030 128AA-peptides containing known degrons in total (Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>b). As transplantation of a degron confers instability on other proteins [<xref ref-type="bibr" rid="CR10">10</xref>], we reasoned that degrons on 128AA-peptides can mediate the degradation of 128AA-peptides as well. Thus, we used these 128AA-peptides to train our model. In the training and test stages, AAs in known degrons were labeled as 1, while AAs in the other regions were labeled as 0 (see <xref rid="Sec12" ref-type="sec">Methods</xref> for detail). We first trained a model (model 0) on 128AA-peptides from 240 randomly selected degrons and tested it on the other 63 degrons. As shown in Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>c, model 0 attained an AUC of 0.8807. This result suggested that we can use the BERT-based model to predict degrons from protein sequences rather than only from motif matches.</p>
      <p id="Par34">Next, we explored whether the BERT-based model can predict degrons bound by E3s not present in our dataset. If the model trained on known degrons bound by a set of E3s can predict that of other E3s, we can infer that our model can discover degrons of new classes. Ideally, degrons used for training and test should be dissimilar in sequence. As it is hard to measure the similarity of degrons bound by different E3s, we grouped 303 known degrons into five clusters using sequence alignment [<xref ref-type="bibr" rid="CR28">28</xref>]. As shown in Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>d, clusters 1, 2, 4, and 5 possessed dominant classes accounting for about 50 percent, while cluster 3 lacked dominant class and acted as a trash bin during clustering. Next, we built five models, trained each model on degrons from four clusters, and tested each model on degrons of the remaining cluster (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S1d,e,f). As shown in Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>c, models 1, 2, and 5 performed well in predicting degrons dissimilar with training degrons. Given the diversity of degrons in cluster 3, the performance of model 3 was also satisfactory. The dominant class in cluster 4 is phosphorylation-dependent degrons SCF_TRCP1 [<xref ref-type="bibr" rid="CR29">29</xref>] (Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>d); as the training degrons of model 4 are mostly modification-independent, model 4 might ignore PTM-related information in the BERT-encoding matrix and performed relatively poorly in predicting phospho-degrons. Overall, these results suggested that even though degrons in different clusters have little sequence homology, they share features beyond the primary sequence that can be captured by the BERT-based model.</p>
      <p id="Par35">To evaluate the importance of information in the BERT-encoding matrix in predicting degrons, we compared the BERT-based model with a new predictor possessing similar architecture and number of trainable parameters, except that it took one-hot encoding as input (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S1g). We trained and tested the one-hot model using the same strategy as the BERT-based model and found that the BERT-based model significantly outperformed the one-hot model in predicting degron in five clusters (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S1d,e,h). This result suggested that the rich information encoded in the TAPE BERT-encoding matrix helps our model discover novel degrons dissimilar to training degrons.</p>
      <p id="Par36">In summary, these findings suggested that the BERT-based model can be used as an alternative to feature integrating degron predictors and has wilder scope of application. In addition, our model can predict degrons of new sequence patterns with satisfy performance; thus, it can be used to discover new degrons proteome-widely.</p>
    </sec>
    <sec id="Sec4">
      <title>Degpred expands the degron landscape and assists in identifying degrons from motif matches</title>
      <p id="Par37">Models 1â5 trained on degrons with different sequence patterns represent different aspects of degron properties. Thus, we assembled models 1â5 to build Degpred to take full advantage of known degrons and provide more comprehensive predictions (Fig.Â <xref rid="Fig2" ref-type="fig">2</xref>a). Degpred averages outputs from five models to score all AAs of the input protein. Taking 0.3 as the cut-off, Degpred attained a false discovery rate (FDR) of 0.512 (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S2a) and predicted 46,621 degrons present in the human proteome (UniProt [<xref ref-type="bibr" rid="CR23">23</xref>] human reviewed proteins) (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S1).<fig id="Fig2"><label>Fig. 2</label><caption><p>Degpred expands the degron landscape and assists in identifying degrons from motif matches. <bold>a</bold> A schematic diagram to illustrate the process of Degpred in predicting degrons, the dimensions of matrixes and vectors in the prediction process are labeled below. <bold>b</bold> Upper penal: Venn diagram showing the counts and overlap of Degpred degrons and ELM motif matches in the human proteome. Lower penal: distribution of Degpred scores of predicted degrons overlapped and not overlapped with ELM motif matches. The green vertical line represents the median score of overlapped degrons. <bold>c</bold> A schematic representation of how Î²TrCP binds substrates, di-phosphorylation on the motif match is necessary for the binding. Mammal genomes encode Î²TrCP1 and Î²TrCP2 that recognize the same degron motif [<xref ref-type="bibr" rid="CR29">29</xref>], we did not distinguish them in our analysis. <bold>d</bold> Statistics of Î²TrCP motif matches overlapped with Degpred degrons (Degpred_TRCP, blue) or not overlapped with Degpred degrons (Other_TRCP, green). <bold>e</bold> Counts of phosphorylation sites occurring on Degpred_TRCP and Other_TRCP. <italic>P</italic>-value was calculated using the chi-square test. <bold>f</bold> Counts of Ub-sites occurring near Degpred_TRCP and Other_TRCP. <italic>P</italic>-value was calculated using Fischer's exact test. <bold>g</bold> Comparison of Degpred_TRCP and Other_TRCP containing proteins in BioID and AP-MS based high-throughput Î²TrCP substrates. <italic>P</italic>-values were calculated using Fischerâs exact test</p></caption><graphic xlink:href="12915_2022_1364_Fig2_HTML" id="MO2"/></fig></p>
      <p id="Par38">To provide an overview of degrons predicted by Degpred, we first compared Degpred degrons with about 55,000 ELM motif matches in the human proteome and found that only 5522 Degpred degrons overlap with ELM motif matches (Fig.Â <xref rid="Fig2" ref-type="fig">2</xref>b). We further analyzed the averaged Degpred score of degrons that match ELM motifs and degrons that do not match ELM motifs. As shown in Fig.Â <xref rid="Fig2" ref-type="fig">2</xref>b, more than 41% of not overlapped degrons possess Degpred scores higher than the median score of overlapped degrons. Even though most training degrons were initially identified through ELM motifs, over 88% of Degpred degrons were beyond those discovered using motifs. These results suggested that Degpred expands the degron landscape. Next, we investigated the relationship between terminus located Degpred degrons and N-end and C-end destabilizing peptides in high-throughput GPS experiments [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR17">17</xref>], which also constitute the training set of deepDegron [<xref ref-type="bibr" rid="CR11">11</xref>]. Unexpectedly, we found that both Degpred degrons and known degrons tend to act as stabilizing peptides in GPS experiments (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S2b). This discordance might be because destabilizing peptides in the GPS experiment are a mixture of multiple functional peptides not limited to degrons [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Further investigations are needed to explore the underlying mechanism of destabilizing peptides in the high-throughput experiment.</p>
      <p id="Par39">Another major disadvantage of motif matching constitutes its high false-positive rate due to only considering local sequence patterns. We investigated whether Degpred can screen real degrons from motif matches by testing Degpred on the motif matches of extensively studied E3 Î²TrCP. The degron of Î²TrCP requires a special sequence patterns and di-phosphorylation to be recognized [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>] (Fig.Â <xref rid="Fig2" ref-type="fig">2</xref>c). The motif of Î²TrCP matches 1068 segments on 953 proteins in the human proteome, and 306 matches on 298 proteins overlap with Degpred degrons (Fig.Â <xref rid="Fig2" ref-type="fig">2</xref>d). To compare the possibility of motif matches with and without Degpred signal functioning as degrons, we first surveyed phosphorylation sites in the database PhosphoSitePlus [<xref ref-type="bibr" rid="CR31">31</xref>] and Ub-sites in the database dbPTM [<xref ref-type="bibr" rid="CR32">32</xref>]. Because real degrons bound by Î²TrCP possess two phosphorylation sites and are rich in Ub-sites located within 20 AAs [<xref ref-type="bibr" rid="CR7">7</xref>]. As shown in Fig.Â <xref rid="Fig2" ref-type="fig">2</xref>e, a higher proportion of Degpred-screened matches were phosphorylated compared to the other matches, both single-phosphorylation and di-phosphorylation. Moreover, we found that Ub-sites were significantly enriched within 20 AAs of Degpred-screened matches compared to the other matches (Fig.Â <xref rid="Fig2" ref-type="fig">2</xref>f). Next, we analyzed potential Î²TrCP substrates identified by proximity-dependent biotin labeling (BioID) [<xref ref-type="bibr" rid="CR30">30</xref>] and affinity purification mass spectrometry (AP-MS) [<xref ref-type="bibr" rid="CR29">29</xref>]. As shown in Fig.Â <xref rid="Fig2" ref-type="fig">2</xref>g, proteins with Degpred-screened matches were identified at higher rates in both experiments compared to proteins with the other matches. These results suggested that Degpred helps identify real degrons from motif matches.</p>
      <p id="Par40">Overall, our deep learning degron predictor Degpred identifies novel degrons with new sequence patterns and helps reduce the false-positive rate of motif matches.</p>
    </sec>
    <sec id="Sec5">
      <title>Degpred degrons exhibit typical degron properties and are rich in ubiquitination sites nearby</title>
      <p id="Par41">To explore the properties of predicted degrons, we first analyzed the AA composition of Degpred degrons and known degrons. As shown in Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>a, the AA composition of Degpred degrons resembles that of known degrons. Proline (P), glutamic acid (E), serine (S), and tyrosine (T) which were reported to be enriched in degradation signals [<xref ref-type="bibr" rid="CR33">33</xref>] were all enriched in Degpred degrons; S, T, and tyrosine (Y) which can be phosphorylated were enriched in Degpred degrons as well. Further analysis showed that not only phosphorylation sites, but also N-linked Glycosylation and Methylation sites were enriched in Degpred degrons (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S2c). These results indicated that Degpred successfully learns the correct AA preference of known degrons, and suggested that some PTMs might act as degron regulators and cross-talk with ubiquitination.<fig id="Fig3"><label>Fig. 3</label><caption><p>Properties of Degpred degrons and comparison with motif-based methods. <bold>a</bold> The AA composition of known degrons, Degpred degrons, and the human proteome, AAs are grouped based on their properties. <bold>bâd</bold> Distributions of predictions of intrinsic disorder, molecular recognition feature, and accessible surface area of predicted degrons in Degpred (blue), Motif_RF (orange), ELM motif matching (green), and random peptides from human proteome (gray, see <xref rid="Sec12" ref-type="sec">Methods</xref> for detail). The intrinsic disorder was predicted with ESpritz-DisProt; the molecular recognition feature was predicted with MoRFchibi; the accessible surface area was predicted with ASAquick. <italic>P</italic>-values were calculated using two sides <italic>T</italic>-test. <bold>eâg</bold> Percentages of lysine, Ub-site, and Ub-lysine in the flanking 50 AAs of predicted degrons in Degpred (blue), Motif_RF (orange), and ELM motif matching (green), averages of the human proteome are displayed in gray. Both sides of predicted degrons were considered</p></caption><graphic xlink:href="12915_2022_1364_Fig3_HTML" id="MO3"/></fig></p>
      <p id="Par42">Furthermore, we compared the properties of predicted degrons of Degpred, ELM motif matching and Motif_RF [<xref ref-type="bibr" rid="CR20">20</xref>]. As Motif_RF utilized 11 features including intrinsically disordered regions, MoRFs, solvent accessibility, and flanking ubiquitinated Ks to predict possible degrons, we first compared these sequence properties of predicted degrons of three methods. As expected, Motif_RF predicted degrons scored higher in the predictions of intrinsically disordered regions, MoRFs, and solvent accessibility [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>] than ELM motif matches and random peptides from the human proteome (Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>bâd). Surprisingly, Degpred degrons also scored higher in these predictions (Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>bâd), which indicates that Degpred captures correct sequence features of degrons. Next, we surveyed Ks and Ub-sites [<xref ref-type="bibr" rid="CR32">32</xref>] around predicted degrons of three methods. As shown in Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>e, Ks were enriched around Degpred degrons, which provides a suitable environment for E3s to ubiquitinate substrates after binding to degrons. In addition, we found that both Ub-sites and ubiquitinated Ks were enriched around Degpred degrons as well (Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>f, g). In comparison, Ks, Ub-sites, and ubiquitinated Ks were randomly distributed around ELM and Motif_RF predicted degrons. These results indicated that Degpred degrons might mediate ubiquitination of flanking Ks.</p>
      <p id="Par43">In summary, Degpred degrons exhibit typical degron properties and might promote ubiquitination of nearby Ks, supporting the assumption that Degpred degrons constitute the binding sites of E3s.</p>
    </sec>
    <sec id="Sec6">
      <title>Predicting binding E3s of degrons using calculated motifs</title>
      <p id="Par44">After predicting degrons, we set out to predict the regulatory E3s for Degpred degrons. The most straightforward method is to match degrons with E3 motifs as used in motif-based methods, but only a small number of experimentally identified E3 motifs were available. Here, we computationally generated E3 motifs using Degpred degrons on substrates in our collected E3-substrate interactions (ESIs) dataset (Fig.Â <xref rid="Fig4" ref-type="fig">4</xref>a, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S3a, Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Table S2, see <xref rid="Sec12" ref-type="sec">Methods</xref> for detail). We chose 55 E3s with at least ten substrates in the ESI dataset and calculated their motifs respectively. For each E3, we used GibbsCluster [<xref ref-type="bibr" rid="CR28">28</xref>] to align Degpred degrons on its substrates and drop dissimilar outliers, which might be the binding sites of other E3s. Subsequently, we generated motifs from the aligned Degpred degrons for each E3 (Fig.Â <xref rid="Fig4" ref-type="fig">4</xref>a, see <xref rid="Sec12" ref-type="sec">Methods</xref> for detail). As shown in Fig.Â <xref rid="Fig4" ref-type="fig">4</xref>b, the calculated motifs for Î²TrCP, SPOP, and FZR1 resemble their experimentally identified motifs [<xref ref-type="bibr" rid="CR16">16</xref>]. In addition, we generated motifs for four HECT E3s (WWP1, WWP2, SMURF2, NEDD4L) which recognize proline-rich motifs through the WW domain [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. Four generated HECT E3 motifs were rich in proline (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S3b). These results indicated that our procedure to generate motifs is reliable.<fig id="Fig4"><label>Fig. 4</label><caption><p>E3 motifs calculation and evaluation. <bold>a</bold> Workflow of motifs calculation. 1. Summary of the ESI dataset collected from PubMed and related works. 2. Fifty-five E3s possessing at least ten substrates in the collected ESI dataset were selected for motif calculation. 3. Predicting Degpred degrons on substrates in the ESI dataset for each E3. 4. Degron alignment and outlier removal with GibbsCluster for each E3. 5. Aligned regions present on degrons were considered to represent the binding sites for each E3. 6. Motif calculation using aligned peptides for each E3. 7. Cut-off calculation, degrons with motif matching scores larger than the cut-off were predicted as binding degrons of the E3. <bold>b</bold> Comparison of our generated motifs of Î²TrCP, SPOP, and FZR1 with their experimentally verified motifs in the ELM database. ELM motifs are represented as regular expressions, and consistent regions are highlighted in red. <bold>c</bold> Distribution of normalized maximal motif matching scores for our ESIs, the ESIs collected in Ubibrowser2.0 and not in our ESIs, and random pairs. Kernel density estimate plot showing the distribution of scores. The maximal motif matching scores were normalized to <italic>Z</italic>-scores for each E3 respectively. <bold>d</bold> Comparison of Ub-site abundance change and protein abundance change of predicted SPOP substrates in three methods after SPOP overexpression. Abundances of replicate 1 in original paper [<xref ref-type="bibr" rid="CR38">38</xref>] were compared, and the results of replicate 2 were identical (data not shown). ChenESI predicted 1195 SPOP substrates and 867 of them were detected in the SPOP overexpression MS; Ubibrowser2.0 predicted 892 SPOP substrates and 622 of them were detected in the MS; we selected the top 2000 predicted SPOP substrates and 669 of them were detected in the MS. Kernel density estimate plots showing the distribution of the ratios after and before SPOP overexpression</p></caption><graphic xlink:href="12915_2022_1364_Fig4_HTML" id="MO4"/></fig></p>
      <p id="Par45">To evaluate the ability of our generated motifs to predict ESIs, we defined a score to measure the binding possibility of an E3 and a substrate: we scored all Degpred degrons of the substrate with the E3 motif and selected the maximal motif matching score to represent the binding possibility. As shown in Fig.Â <xref rid="Fig4" ref-type="fig">4</xref>c, our collected ESIs possessed significantly higher scores than random pairs. In addition, the manually collected ESIs of Ubibrowser2.0 [<xref ref-type="bibr" rid="CR21">21</xref>] not in our dataset also had higher scores. This finding indicated that our generated motifs could discover new ESIs. Furthermore, we compared generated motifs and ChenESI [<xref ref-type="bibr" rid="CR22">22</xref>] on manually collected ESIs of Ubibrowser2.0. We found that generated motifs and ChenESI predicted similar number of substrates for SPOP and FZR1 (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S3d). Next, we compared generated motifs, Ubibrowser2.0 and ChenESI on ubiquitylome and proteome data measured after SPOP overexpression [<xref ref-type="bibr" rid="CR38">38</xref>]. We found that SPOP substrates from the generated motif showed increased ubiquitination levels and reduced protein levels after SPOP overexpression (Fig.Â <xref rid="Fig4" ref-type="fig">4</xref>d). In contrast, the substrates of ChenESI and Ubibrowser2.0 showed no significant change. Thus, these results suggested that our generated motifs can be used to predict ESIs. More importantly, our generated motifs provide information of binding degrons which is absent in Ubibrowser2.0 and ChenESI.</p>
      <p id="Par46">Finally, we set out to construct a protein degradation regulatory network using Degpred degrons and generated motifs. We calculated cut-offs for motifs (Fig.Â <xref rid="Fig4" ref-type="fig">4</xref>a) and used the cut-offs to estimate whether an E3 will bind a predicted degron (see <xref rid="Sec12" ref-type="sec">Methods</xref> for detail). To assess the ability of 55 generated motifs to discover real ESIs, we predict our collected ESIs using 55 motifs. We found that 71% (39/55) of motifs can predict at least 40% of collected substrates (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S3c, Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Table S3). We selected these 39 motifs to construct a protein degradation regulatory network, which consists of 25695 ESIs between 39 E3s and 8754 substrates (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S3e, Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Table S3).</p>
      <p id="Par47">In summary, we generated E3 motifs using Degpred and our collected ESI dataset. These motifs expanded known E3 motifs in the ELM database and enabled us to predict new ESIs with binding site information.</p>
    </sec>
    <sec id="Sec7">
      <title>E3-degron interactions affect half-lives of substrates</title>
      <p id="Par48">To evaluate the impact of Degpred degrons on the turnover of proteins, we analyzed half-lives of proteins in non-dividing B cells, natural killer cells, monocytes, and hepatocytes [<xref ref-type="bibr" rid="CR39">39</xref>]. As shown in Fig.Â <xref rid="Fig5" ref-type="fig">5</xref>a, proteins characterized by dense degrons tend to possess shorter lifespans, which was more significant for proteins with at least five degrons per 1000 AAs. As degrons are more frequent in disordered regions and disorder fraction is positively correlated with degradation rates [<xref ref-type="bibr" rid="CR19">19</xref>], we analyzed proteins with disorder fractions of 0â10%, 10â30%, 30â100%, respectively, and found that proteins with dense degrons own shorter half-lives in three groups (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S4). This finding suggested that proteins with more degrons are under stricter regulation of the UPS and are thus degraded faster. To investigate whether different E3s tend to regulate substrates with different half-lives, we compared the half-lives of predicted substrates of different E3s. As shown in Fig.Â <xref rid="Fig5" ref-type="fig">5</xref>b, predicted substrates of TRIM63, Î²TrCP, NEDD4L, and HUWE1 tend to live shorter, while predicted substrates of TRIM32, FBXL15, PJA1, and FBXL7 tend to possess longer half-lives.<fig id="Fig5"><label>Fig. 5</label><caption><p>E3-degron interactions impact half-lives of substrates. <bold>a</bold> Distribution of half-lives for proteins with different densities of degrons in four non-dividing cell types. The half-lives used were replicate 1 of four cell types in original paper [<xref ref-type="bibr" rid="CR39">39</xref>], and the results of replicate 2 were identical (data not shown). Kernel density estimate plot showing the distribution of log10(half-life +â1). <bold>b</bold> Distribution of half-lives of predicted substrates for each E3. The minimal half-lives in eight experiments of four non-dividing cell types (two replicates per cell type) [<xref ref-type="bibr" rid="CR39">39</xref>] for substrates were used, and E3s were sorted by the median half-lives of their predicted substrates. <bold>c</bold> Half-life experiments of mutated and wild-type CBX6, the experiment is repeated once (Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Table S4). <bold>d</bold> Co-immunoprecipitation experiment between mutated and wild-type CBX6 with SPOP, the experiment is repeated once (Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Table S4). Cell lysates were incubated with anti-HA agarose beads, and the immunoprecipitates were analyzed by Western Blot with anti-HA and anti-SPOP antibodies</p></caption><graphic xlink:href="12915_2022_1364_Fig5_HTML" id="MO5"/></fig></p>
      <p id="Par49">Then, to further verify that predicted degrons prompt protein degradation and mediate E3 binding, we conducted experiments on Chromobox protein homolog 6 (CBX6). CBX6 possessed three Degpred degrons, and segment 269-273 (DARSS) was predicted to be bound by SPOP; CBX6 contains no ELM SPOP motif match. As S is enriched in our generated SPOP motif and is reported to be important in binding with SPOP [<xref ref-type="bibr" rid="CR13">13</xref>], we mutated DARSS to DARAA. Mutating two AAs can also minimize the impact on protein folding and stability. We transfected wild-type and mutated CBX6 plasmids into HEK293T cells respectively, and cultured cells for 36âh to compare the expression of the transgenes. As shown in Fig.Â <xref rid="Fig5" ref-type="fig">5</xref>c, wild-type CBX6 had much less expression than the mutant, which indicated that mutated CBX6 is more stable in cells. Subsequently, we added cycloheximide to inhibit protein synthesis and found that mutated CBX6 was degraded slower than wild-type CBX6 (Fig.Â <xref rid="Fig5" ref-type="fig">5</xref>c). Next, to test whether DARSS on CBX6 interacts with SPOP, we transfected SPOP and wild-type or mutated CBX6 plasmids into HEK293T cells and conducted co-immunoprecipitation experiments. As shown in Fig.Â <xref rid="Fig5" ref-type="fig">5</xref>d, CBX6 and SPOP co-immunoprecipitated, and mutating CBX6 weakened the interaction with SPOP. These findings indicated that DARSS presenting on CBX6 represents a binding degron of SPOP.</p>
      <p id="Par50">Together, these results demonstrated that E3-degron interactions are principally linked to the control of protein half-lives and different E3s regulate substrates with different degradation rates, which implies that E3 might differ in degradation ability.</p>
    </sec>
    <sec id="Sec8">
      <title>Degron-related mutations on short-lived proteins might drive cancer</title>
      <p id="Par51">Defects in degrons and E3s have been implicated in nearly all hallmarks of cancer [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. Previous studies found that highly mutated driver regions in cancer contain many known degrons [<xref ref-type="bibr" rid="CR40">40</xref>], and degron-affecting mutations are positively selected in tumorigenesis [<xref ref-type="bibr" rid="CR20">20</xref>]. By comparing Degpred degrons with these results, we found that Degpred degrons are enriched in the highly mutated driver regions (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S5a), including well-known degrons on TP53, MYC, CTNNB1, NFE2L2, and other newly predicted degrons (Additional file <xref rid="MOESM6" ref-type="media">6</xref>: Table S5). Besides, motif matches that overlapped with Degpred degrons are under more stringent selection in tumorigenesis than the other motif matches (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S5b). However, previous studies were limited by using a biased degron set and failed to link degrons to E3s. Here, we investigated alterations of the expanded degron landscape in human cancers and explored the importance of binding E3s in tumorigenesis. We analyzed mutations in 33 cancer types of The Cancer Genome Atlas (TCGA) [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>] and cancer driver mutations predicted by CATA-population, CATA-cancer, and Structural clustering [<xref ref-type="bibr" rid="CR41">41</xref>].</p>
      <p id="Par52">By comparing the percentage of AAs with mutations in TCGA in degron-related regions (inside and flanking 10 AAs) and other regions, we found that AAs in degron-related regions are susceptible to mutations in cancer compared with AAs in other regions (Fig.Â <xref rid="Fig6" ref-type="fig">6</xref>a). In addition, we found a higher percentage of recurrent mutations (&gt;â=âtwo tumor samples) occur in degron-related regions compared with mutations occurring only once (Fig.Â <xref rid="Fig6" ref-type="fig">6</xref>b). These findings suggested that degron-related mutations are common in human cancer. Then, we investigated degron-related mutations in specific cancer types and proteins. As shown in Fig.Â <xref rid="Fig6" ref-type="fig">6</xref>c, pheochromocytoma and paraganglioma (PCPG), and skin cutaneous melanoma (SKCM) have more mutations in degrons, while brain lower-grade glioma (LGG) contains more mutations near degrons. We next identified hundreds of proteins whose mutations were enriched in degrons in specific cancer types (Fig.Â <xref rid="Fig6" ref-type="fig">6</xref>d, Additional file <xref rid="MOESM6" ref-type="media">6</xref>: Table S5). In addition to well-known degron-mutation enriched proteins such as CTNNB1, NFE2L2, and EPAS1 [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR20">20</xref>], we also identified several proteins rich in degron-mutations that have not been revealed before, such as RXRA in bladder urothelial carcinoma (BLCA), CRNKL1 in skin cutaneous melanoma (SKCM), VPS13D in head and neck squamous cell carcinoma (HNSC), and CIC in LGG. Overall, with the expanded degron landscape, we can explore degron-related mutations in cancer more comprehensively.<fig id="Fig6"><label>Fig. 6</label><caption><p>Characterizing TCGA mutations in predicted degrons. <bold>a</bold> Comparison of mutations occurred in degron-related regions (inside and flanking 10 AAs) and other regions, the rates were calculated by dividing the number of AAs with mutations in TCGA in the regions by the number of all AAs of the regions. <bold>b</bold> Comparison of percentage of degron-related mutations between recurrent mutations (&gt;â=âtwo tumor samples) and other mutations. <bold>c</bold> Percentage of mutations in degrons and near degrons of 33 cancer types. <bold>d</bold> Proteins with mutations enriched in degrons in 33 cancer types, <italic>P</italic> values were calculated using Fischerâs exact test. Proteins with more than one mutation and <italic>P</italic> value less than 0.01 were shown in the scatter plot. <bold>e</bold> Cancer driver percentage of mutations in degron-related regions and other regions. CATA-population distinguishes pathogenic mutations from benign polymorphisms on a population level; CATA-cancer distinguishes between drivers and passenger somatic mutations; structural clustering leverages information from protein structures to predict drivers. <bold>f</bold> Driver mutation percentage in degron-related regions and other regions of short-lived proteins and the other proteins. <bold>g</bold> Normalized percentage of substrates in each function group for each E3. Percentages of substrates in each function group were normalized to <italic>Z</italic>-scores by rows. The bluer the color, the more substrates in this pathway are regulated by the E3. All <italic>P</italic>-values in this figure were calculated using Fischerâs exact test</p></caption><graphic xlink:href="12915_2022_1364_Fig6_HTML" id="MO6"/></fig></p>
      <p id="Par53">Degron-related mutations might interfere with protein degradation and result in abnormal accumulating oncogenes, thus ultimately driving tumorigenesis. We explored whether degron-related mutations tend to act as cancer drivers. Specifically, we focused on recurrent mutations (&gt;â=âtwo tumor samples) which are more pathologically significant and tend to occur in degron-related regions (Fig.Â <xref rid="Fig6" ref-type="fig">6</xref>b). Using three different predictors, we found that degron-related mutations are more likely to function as cancer drivers (Fig.Â <xref rid="Fig6" ref-type="fig">6</xref>e). As degron-enriched proteins tend to be short-lived proteins (Fig.Â <xref rid="Fig5" ref-type="fig">5</xref>a) that regulate metabolism, cell proliferation, and differentiation (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S5c, Additional file <xref rid="MOESM7" ref-type="media">7</xref>: Table S6, [<xref ref-type="bibr" rid="CR43">43</xref>]), we reasoned that degron-related mutations on short-lived proteins might be more pathogenic. To test this hypothesis, we analyzed 1017 short-lived proteins identified by quantitative proteomics in U2OS, HCT116, HEK293T, and RPE1 cell lines [<xref ref-type="bibr" rid="CR44">44</xref>]. The percentages of driver mutations are significantly higher in short-lived proteins than the other proteins (Fig.Â <xref rid="Fig6" ref-type="fig">6</xref>f), which stressed that short-lived proteins are important in tumorigenesis. Surprisingly, we found that degron-related mutations on short-lived proteins tend to function as cancer drivers compared with other mutations. In contrast, there was no significant difference between these mutations on the other proteins. Further, we used another half-life dataset identified in four non-dividing cell types [<xref ref-type="bibr" rid="CR39">39</xref>] and compared proteins with the top 1000 shortest half-lives in at least one experiment with the other proteins. We found that degron-related mutations on short-lived proteins in four non-dividing cell types also tend to drive cancer (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S5d). These results indicated that interfering with the degradation of short-lived proteins is more pathogenic in human cancer, which provides a new perspective for interpreting cancer driver mutations.</p>
      <p id="Par54">Then, we studied E3s in tumorigenesis by analyzing their predicted substrates and binding degrons. We found that approximately two mutations occur in one degron-related region, and the average numbers of mutations in degron-related regions bound by different E3s are comparable (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S5e). In addition, we found that mutations in degron-related regions bound by SPOP and RFWD2 are more likely to function as cancer drivers (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S5f), consistent with previous findings that SPOP and RFWD2 regulate the degradation of critical oncogenes [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. Finally, we analyzed the functions of short-lived substrates of each E3 and identified some well-known functions of these E3s (Fig.Â <xref rid="Fig6" ref-type="fig">6</xref>g), such as CHFR in chromatin remodeling and histone modifications [<xref ref-type="bibr" rid="CR46">46</xref>], SPOP in histone H3K36 trimethylation and alternative splicing [<xref ref-type="bibr" rid="CR47">47</xref>], BIRC3 in regulating the caspase and apoptosis pathways [<xref ref-type="bibr" rid="CR48">48</xref>], and HUWE1 in chromatin modification [<xref ref-type="bibr" rid="CR49">49</xref>]. Together, these results suggested that E3s regulate different pathways by controlling their substrates, and mutations on degrons bound by different E3s might exert different effects in tumorigenesis.</p>
      <p id="Par55">Finally, we highlighted 19021 degron mutations that alter the charge, hydrophobicity, phosphorylation sites, MoRF regions or predicted protein binding residues [<xref ref-type="bibr" rid="CR50">50</xref>] of degrons, and 1524 mutations of flanking lysine (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S5g, Additional file <xref rid="MOESM6" ref-type="media">6</xref>: Table S5). These mutations change the properties of degrons and might hinder their function, thus constitute novel potential cancer drivers.</p>
    </sec>
    <sec id="Sec9">
      <title>The web application</title>
      <p id="Par56">A freely available and fully functional website (<ext-link ext-link-type="uri" xlink:href="http://degron.phasep.pro/">http://degron.phasep.pro/</ext-link>) has been developed to access the collected and predicted data. Users can search all human proteins on the website according to their gene names and UniProt IDs. The detail page for each protein (Fig.Â <xref rid="Fig7" ref-type="fig">7</xref>) includes four sections: (1) basic information about the protein, haploinsufficiency, short half-life, oncogene, and tumor suppressor gene annotations, known degrons and E3s; (2) Degpred degrons and ELM motif matches of the protein; (3) an interactive and scalable interface [<xref ref-type="bibr" rid="CR51">51</xref>] showing the regions of domains, intrinsically disorder score and Degpred score along the sequence; and (4) a sequence viewer displaying AAs of regions of interest on the protein sequence. The introduction and summary of the website are described on the âAboutâ page; all data on the website can be freely downloaded on the âDownloadâ page.<fig id="Fig7"><label>Fig. 7</label><caption><p>The detail page on our website. The detail page of a protein consists of four parts: (1) basic information, function annotations, and known degrons and E3s; (2) Degpred degrons and ELM motif matches; (3) a feature viewer; and (4) a sequence viewer</p></caption><graphic xlink:href="12915_2022_1364_Fig7_HTML" id="MO7"/></fig></p>
    </sec>
  </sec>
  <sec id="Sec10">
    <title>Discussion</title>
    <p id="Par57">Here, we developed a deep learning model to predict hitherto unidentified degrons, allowing for a deeper characterization of the regulatory network involved in protein degradation, both in health and disease. Widely used motif-based methods are limited by few E3 motifs and high false-positive rate. Degpred partially resolves these concerns and captures well-known degron properties. Previous studies showed that machine learning models that integrate multiple protein sequence features perform well in predicting degrons from motif matches [<xref ref-type="bibr" rid="CR20">20</xref>]; our study suggests that by integrating rich information in the BERT-encoding matrix, deep learning models can achieve comparable performance with feature integrating models, which highlights the power of pre-trained BERT-based models in understanding protein functions. Moreover, our model predicts degrons singly from protein sequence, which needs no time-consuming feature annotation process and can be used to explore the impact of sequence alterations on degron potential.</p>
    <p id="Par58">With the expanded degron landscape and the predicted protein degradation regulatory network, we can study their rules in diseases. In this work, we found that degron-related mutations commonly occur in cancers; we also identified hundreds of proteins rich in degron mutations in different cancer types. Based on the predicted degrons, we can infer possible cancer drivers based on interference of protein degradation instead of recurrence of mutations. Mutated degrons might cause abnormally high expression of proteins and further lead to diseases. We reasoned that mutated degrons on concentration-sensitive proteins like haploinsufficient proteins and short-lived proteins might act as cancer drivers. Our analysis reveals that degron-related mutations on short-lived proteins tend to function as cancer drivers. Thus, our tool provides a new perspective to explain the possible rules of cancer mutations in tumorigenesis and identify possible cancer drivers.</p>
    <p id="Par59">However, our study also has several limitations. (1) In the degron and binding E3 prediction part, first, despite the deep learning method provided, which relies on data available during training, degrons can still not be identified for the overwhelming majority of E3 ligases; second, degrons are under dynamic PTM regulations to control the interaction with E3s, and our method fails to distinguish between modification-dependent and independent degrons; third, our method can only assign degrons to 39 E3s. More experimental verified degrons and ESIs are required to classify degrons with different properties and construct a more comprehensive regulation network. (2) In the experimental part, mutation of SPOP binding degron on CBX6 only weakened the interaction. In a study of SPOP and its substrate DAXX, the authors found that SPOP can bind degrons with one mismatched position of ELM motif [<xref ref-type="bibr" rid="CR52">52</xref>]. Even though CBX6 possesses no exact ELM SPOP motif match, there are seven potential binding sites on CBX6 with one mismatch with the ELM SPOP motif, which might mediate the interaction with SPOP. Besides, we mutated DARSS to DARAA to minimize the impact on protein folding and stability, mutating two amino acids might not completely block the interaction. (3) In the half-life and cancer mutation parts, we found many interesting results, but we should note that correlation does not mean causality. There exit other factors like disordered regions, MoRFs that may also contribute to these correlations.</p>
    <p id="Par60">Overall, our collected datasets and Degpred model constitute valuable resources to UPS researchers and protein engineers. Our work also suggests novel applications in protein engineering and drug designation. For example, (1) by deleting or adding degrons to proteins, researchers can control protein abundance to regulate specific functions; (2) researchers can mutate the degrons or block E3-degron interactions to upregulate the expression of tumor suppressors [<xref ref-type="bibr" rid="CR12">12</xref>], which may be a feasible way to treat cancer; and (3) chemists can design PROTAC drugs to link a substrate with a predicted binding E3 to form double bonds between them and achieve higher specificity.</p>
  </sec>
  <sec id="Sec11">
    <title>Conclusions</title>
    <p id="Par61">Our newly designed model provides a powerful and reliable tool for predicting degrons and binding E3s at individual protein and proteome levels. Our work provides novel insights for explaining how a specific subset of driver mutations affect the degradation of proteins and helps bridge the gap between cancer genomics to proteomics. As UPS emerges as a novel therapeutic target in drug discovery and PROTAC drugs show promising effects in clinical trials [<xref ref-type="bibr" rid="CR53">53</xref>], we anticipate that our work will assist in investigating the pathogenesis of related diseases and provide potential therapeutic targets in the near future.</p>
  </sec>
  <sec id="Sec12">
    <title>Methods</title>
    <sec id="Sec13">
      <title>Data augmentation and degron clustering</title>
      <p id="Par62">Degrons of three and four AAs were symmetrically expanded to five and six AAs respectively to provide more information, and for the convenience of clustering (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S1a), degrons at the terminus of proteins were expanded in one direction. 128AA-peptides used to train the model were randomly sampled around degrons from original protein sequences. For degrons near or at the terminus of proteins, we added âXâ to the terminus of the sequence to ensure that degrons were evenly distributed on 128AA-peptides. GibbsCluster [<xref ref-type="bibr" rid="CR28">28</xref>] was used for degrons clustering with parameters: number of clustersâ=â5, motif lengthâ=â5, default values were used for other parameters. Five clusters were used because five-fold cross-validation is widely used in evaluating machine learning models.</p>
    </sec>
    <sec id="Sec14">
      <title>Model architecture, training, and test processes</title>
      <p id="Par63">Models were built using Pytorch 1.4 (<ext-link ext-link-type="uri" xlink:href="https://pytorch.org/">https://pytorch.org/</ext-link>). The input protein sequence of L AAs was embedded using the TAPE BERT-based model [<xref ref-type="bibr" rid="CR27">27</xref>] (<ext-link ext-link-type="uri" xlink:href="https://github.com/songlab-cal/tape">https://github.com/songlab-cal/tape</ext-link>) to a 768 * (L+2) feature matrix or embedded to a 20 * L one-hot encoding matrix. The embedded matrix was passed to bidirectional long short-term memory (biLSTM) layers and fully connected layers. The sigmoid function was used in the final node to ensure the output for each AA was always between 0 and 1. The BERT-based model contains 230,929 trainable parameters, while the one-hot model contains 243,729 trainable parameters.</p>
      <p id="Par64">AAs in degrons were labeled as 1, AAs in the other regions were labeled as 0, and flanking three AAs of degrons were not used in the training and test processes, as these AAs may contribute to E3 binding as well, but were not verified in experiment. In the training process, a dropout rate of 0.3 was employed to avoid overfitting, the batch size was 32. The weighted cross-entropy function was utilized as the loss function, defined as follows:<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$Loss=-\frac{1}{n^2}\sum \left(\left(n-{n}_{deg}\right)y\log \left({y}_{pred}\right)+{n}_{deg}\left(1-y\right)\log \left(1-{y}_{pred}\right)\right)$$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mrow><mml:mi>L</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>s</mml:mi><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:msup><mml:mi>n</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mfrac><mml:mo>â</mml:mo><mml:mfenced close=")" open="("><mml:mfenced close=")" open="("><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi mathvariant="italic">deg</mml:mi></mml:mrow></mml:msub></mml:mfenced><mml:mi>y</mml:mi><mml:mo>log</mml:mo><mml:mfenced close=")" open="("><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mi mathvariant="italic">pred</mml:mi></mml:mrow></mml:msub></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi mathvariant="italic">deg</mml:mi></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>y</mml:mi></mml:mfenced><mml:mo>log</mml:mo><mml:mfenced close=")" open="("><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mi mathvariant="italic">pred</mml:mi></mml:mrow></mml:msub></mml:mfenced></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12915_2022_1364_Article_Equa.gif" position="anchor"/></alternatives></disp-formula>where <italic>n</italic> is the number of all AAs, <italic>n</italic><sub><italic>deg</italic></sub> is the number of AAs in degrons, <italic>y</italic> is the label, and <italic>y</italic><sub><italic>pred</italic></sub> is the predicted value. The training process stopped when the loss did not decrease in the following five epochs. The Adam optimizer with a learning rate of 0.0003 was used to update parameters.</p>
      <p id="Par65">In the test process, 0.5 was used as the cut-off to classify AAs to be in degrons or not. Models were evaluated using the area under the receiver operating characteristic curve (AUC), precision-recall curves, and the following scores:<disp-formula id="Equb"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{precision}=\frac{TP}{TP+ FP}$$\end{document}</tex-math><mml:math id="M4" display="block"><mml:mrow><mml:mi mathvariant="normal">precision</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="italic">TP</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="12915_2022_1364_Article_Equb.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equc"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{recall}=\frac{TP}{TP+ FN}$$\end{document}</tex-math><mml:math id="M6" display="block"><mml:mrow><mml:mi mathvariant="normal">recall</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="italic">TP</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="12915_2022_1364_Article_Equc.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equd"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{FDR}=\frac{FP}{TP+ FP}$$\end{document}</tex-math><mml:math id="M8" display="block"><mml:mrow><mml:mi mathvariant="normal">FDR</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="italic">FP</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="12915_2022_1364_Article_Equd.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Eque"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{accuracy}=\frac{TP+ TN}{TP+ FP+ TN+ FN}$$\end{document}</tex-math><mml:math id="M10" display="block"><mml:mrow><mml:mi mathvariant="normal">accuracy</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>T</mml:mi><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>T</mml:mi><mml:mi>N</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="12915_2022_1364_Article_Eque.gif" position="anchor"/></alternatives></disp-formula>where TP represents the number of AAs in degrons identified correctly, TN represents the number of AAs in other regions identified correctly, FN denotes the number of AAs in degrons identified incorrectly, FP represents the number of AAs in other regions identified incorrectly.</p>
    </sec>
    <sec id="Sec15">
      <title>Comparing the BERT-based model with Motif_RF and MoRFchibi</title>
      <p id="Par66">For the TAPE BERT-based model, the inputs were 128AA-peptides with motif matches located at the center; one 128AA-peptide was generated for each motif match (no data augmentation in this comparison). The predicted scores for AAs in the motif match were averaged to represent the BERT-based model score of the motif match, the average scores were used to calculate cross-entropy loss in the training stage and evaluated in the test stage. Motif_RF was built by the scikit-learn package of python with same parameters as the original paper [<xref ref-type="bibr" rid="CR20">20</xref>]. The input features for Motif_RF were directly downloaded from the supplementary data of the original paper [<xref ref-type="bibr" rid="CR20">20</xref>]. The average MoRFchibi score of AAs in the motif match was used as the MoRFchibi score of the motif match.</p>
      <p id="Par67">Our collected known degrons possessing feature annotations in the supplementary data of the original Motif_RF paper [<xref ref-type="bibr" rid="CR20">20</xref>] constituted the positive dataset (only retaining one degron for the same degrons on different isoforms of one gene); the negative dataset contains motif matches randomly selected from proteins without known degrons. The ratio of positive to negative samples is 1:5. Fivefold cross-validation was used to calculate the AUC of TAPE BERT-based model and Motif_RF; AUC of MoRFchibi was directly calculated on all motif matches in positive and negative datasets.</p>
    </sec>
    <sec id="Sec16">
      <title>Degron prediction</title>
      <p id="Par68">To predict degrons from protein sequence, the average of outputs from models 1â5 was calculated and 0.3 was set as the cut-off. Two predicted degrons with a distance of fewer than 4 AAs were merged, and degrons shorter than 3 AAs were discarded. Due to the O(L2) space complexity of BERT-based models, handling the full length of long proteins requires high computational power. Thus, for proteins shorter than 1000 AAs, the full proteins were used; for proteins longer than 1000 AAs, the proteins were evenly split into ceil(L/1000) parts and predicted separately, where <italic>L</italic> is the length of proteins, and ceil means to round up the value upward to the smallest integer not less than it.</p>
    </sec>
    <sec id="Sec17">
      <title>Properties comparison</title>
      <p id="Par69">MoRFchibi, ASAquick and predicted protein binding residue (SCRIBER) scores were downloaded from DescribePROT [<xref ref-type="bibr" rid="CR50">50</xref>]. MoRF regions and predicted protein binding residues in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S5g were residues with top 5% highest score in the human proteome. ESpritz-Disport [<xref ref-type="bibr" rid="CR34">34</xref>] with default parameters was used to predict disordered regions. Phosphorylation sites were downloaded from PhosphoSitePlus [<xref ref-type="bibr" rid="CR31">31</xref>] (2021.01.19); the other PTM sites were downloaded from dbPTM [<xref ref-type="bibr" rid="CR32">32</xref>] (2020.12.31).</p>
      <p id="Par70">Degpred degrons in Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>bâg were predicted at the cut-off of 0.3 with an FDR of 0.512 at positive: negativeâ=â1:20 (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S2a). Predicted degrons of Motif_RF in Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>bâg were motif matches in the supplementary data of the original paper [<xref ref-type="bibr" rid="CR20">20</xref>] with Prob_DEGRON larger than 0.842, which attained the same FDR at positive: negativeâ=â1:20 with our method. The random peptides used in Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>bâd and Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S2c were peptides of 10 AAs sampled from the human proteome. The number of peptides sampled from a protein of length L is ceil(L/1000), where ceil means to round the value upward to the smallest integer not less than it. About 33,000 random peptides were sampled from the human proteome.</p>
    </sec>
    <sec id="Sec18">
      <title>ESI dataset collection</title>
      <p id="Par71">Nine hundred sixty-five related papers were obtained by searching PubMed with keywords: (E3[Title] OR E3s[Title]) AND (substrate[Title/Abstract] OR substrates[Title/Abstract]). Twenty-seven of 965 papers were retained after the manual screening. Two thousand two hundred seventy-two nonredundant ESIs between 56 human E3s and 1863 substrates were extracted from these studies, and most of them were identified from high throughput experiments. In addition, Chen et al. [<xref ref-type="bibr" rid="CR22">22</xref>] had collected 1790 nonredundant known ESIs from BioGrid [<xref ref-type="bibr" rid="CR54">54</xref>], E3Net [<xref ref-type="bibr" rid="CR55">55</xref>], hUbiquitome [<xref ref-type="bibr" rid="CR56">56</xref>], and UniProt [<xref ref-type="bibr" rid="CR23">23</xref>]; these ESIs were included as well. In total, we obtained 3766 nonredundant ESIs between 307 human E3s and 2713 substrates (Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Table S3).</p>
    </sec>
    <sec id="Sec19">
      <title>Motif calculation and matching</title>
      <p id="Par72">As known substrates from public databases are more reliable than manual high-throughput substrates, for E3s with at least ten known substrates, only known substrates were used to calculate motifs; for E3s with less than ten known substrates, both known substrates and high-throughput substrates were used. Degrons and flanking three AAs on both sides were used in motif calculation and matching. GibbsCluster [<xref ref-type="bibr" rid="CR28">28</xref>] was employed to align these expanded degrons and remove outliers. Given the length of known degrons, the motif length was set to 5-8 AAs, and four motifs with lengths of 5-8 would be generated for each E3. A trash cluster was used to remove outliers, and the trash cluster threshold was set to 4. Alignment cores with lengths of 5-8 generated by GibbsCluster [<xref ref-type="bibr" rid="CR28">28</xref>] were used to construct four position-specific score matrixes (PSSMs) for each E3. For a PSSM, <italic>S</italic><sub><italic>i</italic>, <italic>a</italic></sub> represents the score of amino acid <italic>a</italic> on position <italic>i</italic>, and was calculated as:<disp-formula id="Equf"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${S}_{i,a}={\log}_2\left(\frac{\left({C}_{i,a}+1\right)/\left(N+20\right)}{F_a}\right)$$\end{document}</tex-math><mml:math id="M12" display="block"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mo>log</mml:mo><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mfenced close=")" open="("><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mfenced><mml:mo stretchy="false">/</mml:mo><mml:mfenced close=")" open="("><mml:mi>N</mml:mi><mml:mo>+</mml:mo><mml:mn>20</mml:mn></mml:mfenced></mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mfrac></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12915_2022_1364_Article_Equf.gif" position="anchor"/></alternatives></disp-formula>where <italic>C</italic><sub><italic>i</italic>, <italic>a</italic></sub> is the number of amino acid <italic>a</italic> on position <italic>i</italic> in alignment cores, <italic>N</italic> is the number of alignment cores, and <italic>F</italic><sub><italic>a</italic></sub> is the frequency of amino acid <italic>a</italic> in the human proteome.</p>
      <p id="Par73">For an equal-length peptide with a PSSM, the matching score was calculated by adding scores of all AAs in the peptide; for a peptide longer than a PSSM, the peptide was slid across with the PSSM, and the highest matching score among all positions was used as the matching score; for a peptide shorter than a PSSM, no matching score was provided. To calculate the cut-off for a PSSM, we reversed it and used the reversed PSSM to score 1,000,000 equal-length peptides randomly sampled from human proteome, the top 1/2000 score was used as the cut-off for the PSSM. For each E3, the ability of four PSSMs to capture known substrates was evaluated, and the PSSM with higher recall rate was selected as the motif representing the E3.</p>
      <p id="Par74">Seven of 39 E3s with calculated motifs possess ELM motifs (SPOP: DEG_SPOP_SBC_1, SIAH1 and SIAH2: DEG_SIAH_1, Î²TrCP: DEG_SCF_TRCP1_1, VHL: DEG_ODPH_VHL_1, RFWD2: DEG_COP1, FZR1: DEG_APCC_KENBOX_2). Four of 16 E3s without calculated motifs possess ELM motifs (SKP2: DEG_SCF_SKP2-CKS1_1, MDM2: DEG_MDM2_SWIB_1, FBXW7: DEG_SCF_FBW7_1 and DEG_SCF_FBW7_2, CDC20: DEG_APCC_DBOX_1).</p>
    </sec>
    <sec id="Sec20">
      <title>Public data and gene ontology enrichment</title>
      <p id="Par75">For SPOP overexpressed ubiquitylome and proteome data [<xref ref-type="bibr" rid="CR38">38</xref>], only data of replicate 1 was compared, and the results of replicate 2 were identical (data not shown). The half-lives used in Fig.Â <xref rid="Fig5" ref-type="fig">5</xref>a and Fig. S<xref rid="MOESM1" ref-type="media">4</xref> were replicate 1 of four cell types [<xref ref-type="bibr" rid="CR39">39</xref>], and the results of replicate 2 were identical (data not shown). TCGA mutation data were downloaded from <ext-link ext-link-type="uri" xlink:href="https://gdc.cancer.gov/about-data/publications/mc3-2017">https://gdc.cancer.gov/about-data/publications/mc3-2017</ext-link> and processed according to ref. [<xref ref-type="bibr" rid="CR41">41</xref>]; cancer driver mutation data were downloaded from <ext-link ext-link-type="uri" xlink:href="https://gdc.cancer.gov/about-data/publications/pancan-driver">https://gdc.cancer.gov/about-data/publications/pancan-driver</ext-link>.</p>
      <p id="Par76">Gene ontology enrichment was conducted using Cytoscape package clueGO (version 2.5.8, <ext-link ext-link-type="uri" xlink:href="https://apps.cytoscape.org/apps/cluego">https://apps.cytoscape.org/apps/cluego</ext-link>). The detailed parameters are available in Additional file <xref rid="MOESM7" ref-type="media">7</xref>: Table S6.</p>
    </sec>
    <sec id="Sec21">
      <title>Cell culture and transfection</title>
      <p id="Par77">HEK293T cells were grown in DMEM (Biological Industries) supplemented with 10% fetal bovine serum. Cells were cultured in a 37âÂ°C/5% CO2 incubator. Plasmids were transfected into cells with PEI (Hannothch), the culture medium was changed after 6âh of transfection, and cells were maintained for another 36âh.</p>
    </sec>
    <sec id="Sec22">
      <title>Plasmids and antibodies</title>
      <p id="Par78">Wide type and mutated CBX6 plasmids were synthesized by GENEWIZ. HA-tagged wild-type and mutated CBX6 were cloned into plvx-IRES-zsgreen. The plvx-empty and plvx-myc-SPOP were provided by Dr. Hong Wu lab.</p>
      <p id="Par79">Anti-HA: Santa Cruz Biotechnology sc-7392; Anti-GAPDH: Cell Signaling Technology D16H11; Anti-SPOP was homemade in Dr. Hong Wu lab.</p>
    </sec>
    <sec id="Sec23">
      <title>Cycloheximide chasing assay</title>
      <p id="Par80">Wide type or mutated CBX6 plasmids were transfected into HEK293T cells. Cycloheximide (MCE 100âÎ¼g/ml) was added into the medium after incubation and cells were collected at different time points. Cells were washed with PBS, lysed in RIPA buffer (50âmM Tris-Cl pHâ7.4, 150âmM NaCl, 1% TrintonX-100, 1% sodium deoxycholate, 1% SDS, plus protease inhibitor cocktails (Thermo Scientific)). Cell lysates were analyzed by Western Blot with indicated antibodies.</p>
    </sec>
    <sec id="Sec24">
      <title>Co-immunoprecipitation assay</title>
      <p id="Par81">Myc-SPOP and wide type or mutated HA-CBX6 were transfected into HEK293T cells. Cell lysates were prepared 48âh after transfected in Sucrose-NP40 lysis buffer (25âmM Tris-Cl pHâ7.5, 150âmM NaCl, 5âmM MgCl2, 1âmM DTT, 1âmM PMSF, 10âmM NaF, 1âmM NaVO3, 2âmM EDTA, 0.25âM Sucrose and 0.5% NP40 and protease inhibitors (Roche 04906837001)) for 30âmin on ice. Cell lysates were spun at 15,000ârpm for 15âmin at 4âÂ°C, and the supernatants were incubated with pre-washed anti-HA (Thermo 26182) agarose beads for 4âh in the cold room. The immunoprecipitates were collected by centrifugation and washed four times with wash buffer (150âmM NaCl, 25âmM Tris-Cl pHâ7.5, 0.1% NP40, 5âmM MgCl<sub>2</sub>, 1âmM DTT, 1âmM PMSF). Precipitations were analyzed by Western blot after 90âÂ°C 10âmin boiled in 1âÃâloading buffer (0.2âM Tris-Cl pHâ6.8, 0.02âg/mL SDS, 1âmg/mL Bromophenol Blue, 10% glycerinum, 1% Î²-Me).</p>
    </sec>
    <sec id="Sec25">
      <title>Western Blot</title>
      <p id="Par82">Cell lysates were boiled in protein loading buffer and centrifuged at 14,000g. The protein supernatants were subjected to 10% SDS-PAGE. Proteins were then transferred into 0.45âÎ¼m PVDF membranes (Millpore), and the membrane were blocked in 5% BSA for 1âh and were incubated with primary antibodies overnight at 4âÂ°C. After washing with TBST (0.5% Tween-20), membranes with protein were incubated with secondary antibody for 2âh at room temperature. After washing with TBST (0.5% Tween-20), proteins of interest were visualized using the enhanced chemiluminescence system (Thermo). Uncropped western blots were provided in Additional file <xref rid="MOESM8" ref-type="media">8</xref>.</p>
    </sec>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Information</title>
    <sec id="Sec26">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="12915_2022_1364_MOESM1_ESM.pdf">
            <caption>
              <p><bold>Additional file 1: Figure S1</bold>. Architecture of the model and comparison with other predictors. <bold>Figure S2</bold>. Cut-off determination, comparison with GPS experiment, and PTMs in degrons. <bold>Figure S3</bold>. Statistics of collected and predicted ESI datasets, and motifs for HECT E3s. <bold>Figure S4</bold>. Half-lives of proteins with different disorder fractions and degron density. <bold>Figure S5</bold>. Functional analysis of degron-related mutations and E3s.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM2">
          <media xlink:href="12915_2022_1364_MOESM2_ESM.xlsx">
            <caption>
              <p><bold>Additional file 2: Table S1</bold>. Known degrons from ELM and three previous works, and Degpred degrons on UniProt human reviewed proteins with 0.3 as the cutoff.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM3">
          <media xlink:href="12915_2022_1364_MOESM3_ESM.xlsx">
            <caption>
              <p><bold>Additional file 3: Table S2</bold>. Known ESIs and manual collected ESIs.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM4">
          <media xlink:href="12915_2022_1364_MOESM4_ESM.xlsx">
            <caption>
              <p><bold>Additional file 4: Table S3</bold>. Calculated motifs and predicted ESIs.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM5">
          <media xlink:href="12915_2022_1364_MOESM5_ESM.xlsx">
            <caption>
              <p><bold>Additional file 5: Table S4</bold>. Individual values for figures where the number of independent replicates is less than 6.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM6">
          <media xlink:href="12915_2022_1364_MOESM6_ESM.xlsx">
            <caption>
              <p><bold>Additional file 6: Table S5</bold>. Degrons in driver regions, proteins rich in degron mutations, and novel potential driver mutations in Degpred degrons.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM7">
          <media xlink:href="12915_2022_1364_MOESM7_ESM.xlsx">
            <caption>
              <p><bold>Additional file 7: Table S6</bold>. Enriched function groups of short-lived proteins.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM8">
          <media xlink:href="12915_2022_1364_MOESM8_ESM.pdf">
            <caption>
              <p><bold>Additional file 8.</bold> Uncropped western blots.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>AA</term>
        <def>
          <p id="Par4">Amino acid</p>
        </def>
      </def-item>
      <def-item>
        <term>AP-MS</term>
        <def>
          <p id="Par5">Affinity purification mass spectrometry</p>
        </def>
      </def-item>
      <def-item>
        <term>AUC</term>
        <def>
          <p id="Par6">The area under the receiver operating characteristic curve</p>
        </def>
      </def-item>
      <def-item>
        <term>BLCA</term>
        <def>
          <p id="Par7">Bladder Urothelial Carcinoma</p>
        </def>
      </def-item>
      <def-item>
        <term>CBX6</term>
        <def>
          <p id="Par8">Chromobox protein homolog 6</p>
        </def>
      </def-item>
      <def-item>
        <term>ChenESI</term>
        <def>
          <p id="Par9">A E3-substrate predictor developed by Chen et al.</p>
        </def>
      </def-item>
      <def-item>
        <term>E3</term>
        <def>
          <p id="Par10">E3 ubiquitin ligase</p>
        </def>
      </def-item>
      <def-item>
        <term>ESI</term>
        <def>
          <p id="Par11">E3-substrate interaction</p>
        </def>
      </def-item>
      <def-item>
        <term>GPS</term>
        <def>
          <p id="Par12">Global Protein Stability</p>
        </def>
      </def-item>
      <def-item>
        <term>HNSC</term>
        <def>
          <p id="Par13">Head and Neck Squamous Cell Carcinoma</p>
        </def>
      </def-item>
      <def-item>
        <term>LGG</term>
        <def>
          <p id="Par14">Brain Lower Grade Glioma</p>
        </def>
      </def-item>
      <def-item>
        <term>MoRF</term>
        <def>
          <p id="Par15">Molecular recognition feature</p>
        </def>
      </def-item>
      <def-item>
        <term>Motif_RF</term>
        <def>
          <p id="Par16">A degron predictor developed by MartÃ­nez-JimÃ©nez et al.</p>
        </def>
      </def-item>
      <def-item>
        <term>PCPG</term>
        <def>
          <p id="Par17">Pheochromocytoma and paraganglioma</p>
        </def>
      </def-item>
      <def-item>
        <term>PSSM</term>
        <def>
          <p id="Par18">Position-specific score matrix</p>
        </def>
      </def-item>
      <def-item>
        <term>PTM</term>
        <def>
          <p id="Par19">Post-translational modification</p>
        </def>
      </def-item>
      <def-item>
        <term>SKCM</term>
        <def>
          <p id="Par20">Skin cutaneous melanoma</p>
        </def>
      </def-item>
      <def-item>
        <term>TCGA</term>
        <def>
          <p id="Par21">The Cancer Genome Atlas</p>
        </def>
      </def-item>
      <def-item>
        <term>UPS</term>
        <def>
          <p id="Par22">Ubiquitin-proteasome system</p>
        </def>
      </def-item>
      <def-item>
        <term>Ub</term>
        <def>
          <p id="Par23">Ubiquitin</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisherâs Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>We thank Dr. Pilong Li (Tsinghua University, China) and Dr. Chunyu Yu (Hangzhou Normal University, China) for their helpful suggestions.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authorsâ contributions</title>
    <p>T.L., C.H., and H.W. designed the study and wrote the paper. C.H. performed the research and collected and analyzed the data. Y.L. and M.W. carried out experiment verification. All authors read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This work was supported by the National Key Research and Development Program of China [2018YFA0507504, 2021YFF1200900] and the National Natural Science Foundation of China [32070666, 61773025]. M.W. was supported in part by the Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>Both collected and predicted data are provided as additional files and can be downloaded from <ext-link ext-link-type="uri" xlink:href="http://degron.phasep.pro/">http://degron.phasep.pro/</ext-link>. The code is available at 10.5281/zenodo.6722109 or <ext-link ext-link-type="uri" xlink:href="https://github.com/CHAOHOU-97/degpred">https://github.com/CHAOHOU-97/degpred</ext-link>. All data generated or analyzed during this study are included in this published article, its supplementary information files and publicly available repositories.</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar1">
      <title>Ethics approval and consent to participate</title>
      <p id="Par83">Not applicable.</p>
    </notes>
    <notes id="FPar2">
      <title>Consent for publication</title>
      <p id="Par84">Not applicable.</p>
    </notes>
    <notes id="FPar3" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par85">The authors declare that they have no competing interests.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Meszaros</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gibson</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Uyar</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Dosztanyi</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>Degrons in cancer</article-title>
        <source>Sci Signal</source>
        <year>2017</year>
        <volume>10</volume>
        <fpage>470</fpage>
        <pub-id pub-id-type="doi">10.1126/scisignal.aak9982</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ciechanover</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Intracellular protein degradation: From a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting</article-title>
        <source>Best Pract Res Clin Haematol</source>
        <year>2017</year>
        <volume>30</volume>
        <issue>4</issue>
        <fpage>341</fpage>
        <lpage>355</lpage>
        <pub-id pub-id-type="doi">10.1016/j.beha.2017.09.001</pub-id>
        <?supplied-pmid 29156207?>
        <pub-id pub-id-type="pmid">29156207</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Collins</surname>
            <given-names>GA</given-names>
          </name>
          <name>
            <surname>Goldberg</surname>
            <given-names>AL</given-names>
          </name>
        </person-group>
        <article-title>The logic of the 26S proteasome</article-title>
        <source>Cell</source>
        <year>2017</year>
        <volume>169</volume>
        <issue>5</issue>
        <fpage>792</fpage>
        <lpage>806</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2017.04.023</pub-id>
        <?supplied-pmid 28525752?>
        <pub-id pub-id-type="pmid">28525752</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Buchberger</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bukau</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Sommer</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Protein quality control in the cytosol and the endoplasmic reticulum: brothers in arms</article-title>
        <source>Mol Cell</source>
        <year>2010</year>
        <volume>40</volume>
        <issue>2</issue>
        <fpage>238</fpage>
        <lpage>252</lpage>
        <pub-id pub-id-type="doi">10.1016/j.molcel.2010.10.001</pub-id>
        <?supplied-pmid 20965419?>
        <pub-id pub-id-type="pmid">20965419</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kwon</surname>
            <given-names>YT</given-names>
          </name>
          <name>
            <surname>Ciechanover</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>The ubiquitin code in the ubiquitin-proteasome system and autophagy</article-title>
        <source>Trends Biochem Sci</source>
        <year>2017</year>
        <volume>42</volume>
        <issue>11</issue>
        <fpage>873</fpage>
        <lpage>886</lpage>
        <pub-id pub-id-type="doi">10.1016/j.tibs.2017.09.002</pub-id>
        <?supplied-pmid 28947091?>
        <pub-id pub-id-type="pmid">28947091</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Bengtson</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Ulbrich</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Matsuda</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Reddy</surname>
            <given-names>VA</given-names>
          </name>
          <name>
            <surname>Orth</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Chanda</surname>
            <given-names>SK</given-names>
          </name>
          <name>
            <surname>Batalov</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Joazeiro</surname>
            <given-names>CA</given-names>
          </name>
        </person-group>
        <article-title>Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling</article-title>
        <source>PLoS One</source>
        <year>2008</year>
        <volume>3</volume>
        <issue>1</issue>
        <fpage>e1487</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0001487</pub-id>
        <?supplied-pmid 18213395?>
        <pub-id pub-id-type="pmid">18213395</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Guharoy</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bhowmick</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Sallam</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tompa</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Tripartite degrons confer diversity and specificity on regulated protein degradation in the ubiquitin-proteasome system</article-title>
        <source>Nat Commun</source>
        <year>2016</year>
        <volume>7</volume>
        <fpage>10239</fpage>
        <pub-id pub-id-type="doi">10.1038/ncomms10239</pub-id>
        <?supplied-pmid 26732515?>
        <pub-id pub-id-type="pmid">26732515</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Malhis</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Jacobson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gsponer</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>MoRFchibi SYSTEM: software tools for the identification of MoRFs in protein sequences</article-title>
        <source>Nucleic Acids Res</source>
        <year>2016</year>
        <volume>44</volume>
        <issue>W1</issue>
        <fpage>W488</fpage>
        <lpage>W493</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkw409</pub-id>
        <?supplied-pmid 27174932?>
        <pub-id pub-id-type="pmid">27174932</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Van Roey</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Dinkel</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Weatheritt</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Gibson</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Davey</surname>
            <given-names>NE</given-names>
          </name>
        </person-group>
        <article-title>The switches.ELM resource: a compendium of conditional regulatory interaction interfaces</article-title>
        <source>Sci Signal</source>
        <year>2013</year>
        <volume>6</volume>
        <issue>269</issue>
        <fpage>rs7</fpage>
        <?supplied-pmid 23550212?>
        <pub-id pub-id-type="pmid">23550212</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Koren</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Timms</surname>
            <given-names>RT</given-names>
          </name>
          <name>
            <surname>Kula</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>MZ</given-names>
          </name>
          <name>
            <surname>Elledge</surname>
            <given-names>SJ</given-names>
          </name>
        </person-group>
        <article-title>The eukaryotic proteome is shaped by E3 ubiquitin ligases targeting C-terminal degrons</article-title>
        <source>Cell</source>
        <year>2018</year>
        <volume>173</volume>
        <issue>7</issue>
        <fpage>1622</fpage>
        <lpage>1635 e1614</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2018.04.028</pub-id>
        <?supplied-pmid 29779948?>
        <pub-id pub-id-type="pmid">29779948</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tokheim</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Timms</surname>
            <given-names>RT</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Mena</surname>
            <given-names>EL</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ge</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>W</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Systematic characterization of mutations altering protein degradation in human cancers</article-title>
        <source>Mol Cell</source>
        <year>2021</year>
        <volume>81</volume>
        <issue>6</issue>
        <fpage>1292</fpage>
        <lpage>1308 e1211</lpage>
        <pub-id pub-id-type="doi">10.1016/j.molcel.2021.01.020</pub-id>
        <?supplied-pmid 33567269?>
        <pub-id pub-id-type="pmid">33567269</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ruan</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Niu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Xiong</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Jin</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Computational strategy for intrinsically disordered protein ligand design leads to the discovery of p53 transactivation domain I binding compounds that activate the p53 pathway</article-title>
        <source>Chem Sci</source>
        <year>2020</year>
        <volume>12</volume>
        <issue>8</issue>
        <fpage>3004</fpage>
        <lpage>3016</lpage>
        <pub-id pub-id-type="doi">10.1039/D0SC04670A</pub-id>
        <?supplied-pmid 34164069?>
        <pub-id pub-id-type="pmid">34164069</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yue</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Multiple Ser/Thr-rich degrons mediate the degradation of Ci/Gli by the Cul3-HIB/SPOP E3 ubiquitin ligase</article-title>
        <source>Proc Natl Acad Sci U S A</source>
        <year>2009</year>
        <volume>106</volume>
        <issue>50</issue>
        <fpage>21191</fpage>
        <lpage>21196</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.0912008106</pub-id>
        <?supplied-pmid 19955409?>
        <pub-id pub-id-type="pmid">19955409</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <mixed-citation publication-type="other">Ella H, Reiss Y, Ravid T. The hunt for degrons of the 26S proteasome. Biomolecules. 2019;9(6):230.</mixed-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Iconomou</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Saunders</surname>
            <given-names>DN</given-names>
          </name>
        </person-group>
        <article-title>Systematic approaches to identify E3 ligase substrates</article-title>
        <source>Biochem J</source>
        <year>2016</year>
        <volume>473</volume>
        <issue>22</issue>
        <fpage>4083</fpage>
        <lpage>4101</lpage>
        <pub-id pub-id-type="doi">10.1042/BCJ20160719</pub-id>
        <?supplied-pmid 27834739?>
        <pub-id pub-id-type="pmid">27834739</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kumar</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gouw</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Michael</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>SÃ¡mano-SÃ¡nchez</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Pancsa</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Glavina</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Diakogianni</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Valverde</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Bukirova</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>ÄalyÅ¡eva</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ELMâthe eukaryotic linear motif resource in 2020</article-title>
        <source>Nucleic Acids Res</source>
        <year>2019</year>
        <volume>48</volume>
        <issue>D1</issue>
        <fpage>D296</fpage>
        <lpage>D306</lpage>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <mixed-citation publication-type="other">Timms RT, Zhang Z, Rhee DY, Harper JW, Koren I, Elledge SJ. A glycine-specific N-degron pathway mediates the quality control of protein N-myristoylation. Science. 2019;365(6448):eaaw4912.</mixed-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fishbain</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Inobe</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Israeli</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Chavali</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kago</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Babu</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Matouschek</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Sequence composition of disordered regions fine-tunes protein half-life</article-title>
        <source>Nat Struct Mol Biol</source>
        <year>2015</year>
        <volume>22</volume>
        <issue>3</issue>
        <fpage>214</fpage>
        <lpage>221</lpage>
        <pub-id pub-id-type="doi">10.1038/nsmb.2958</pub-id>
        <?supplied-pmid 25643324?>
        <pub-id pub-id-type="pmid">25643324</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van der Lee</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Lang</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Kruse</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Gsponer</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sanchez de Groot</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Huynen</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Matouschek</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Fuxreiter</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Babu</surname>
            <given-names>MM</given-names>
          </name>
        </person-group>
        <article-title>Intrinsically disordered segments affect protein half-life in the cell and during evolution</article-title>
        <source>Cell Rep</source>
        <year>2014</year>
        <volume>8</volume>
        <issue>6</issue>
        <fpage>1832</fpage>
        <lpage>1844</lpage>
        <pub-id pub-id-type="doi">10.1016/j.celrep.2014.07.055</pub-id>
        <?supplied-pmid 25220455?>
        <pub-id pub-id-type="pmid">25220455</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>MartÃ­nez-JimÃ©nez</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>MuiÃ±os</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>LÃ³pez-Arribillaga</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Lopez-Bigas</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Gonzalez-Perez</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Systematic analysis of alterations in the ubiquitin proteolysis system reveals its contribution to driver mutations in cancer</article-title>
        <source>Nat Can</source>
        <year>2019</year>
        <volume>1</volume>
        <issue>1</issue>
        <fpage>122</fpage>
        <lpage>135</lpage>
        <pub-id pub-id-type="doi">10.1038/s43018-019-0001-2</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <mixed-citation publication-type="other">Wang X, Li Y, He M, Kong X, Jiang P, Liu X, et al. UbiBrowser 2.0: a comprehensive resource for proteome-wide known and predicted ubiquitin ligase/deubiquitinase-substrate interactions in eukaryotic species. Nucleic Acids Res. 2021;50(D1):D719âD728.</mixed-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Xia</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Tekcham</surname>
            <given-names>DS</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ning</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A multidimensional characterization of E3 ubiquitin ligase and substrate interaction network</article-title>
        <source>iScience</source>
        <year>2019</year>
        <volume>16</volume>
        <fpage>177</fpage>
        <lpage>191</lpage>
        <pub-id pub-id-type="doi">10.1016/j.isci.2019.05.033</pub-id>
        <?supplied-pmid 31181401?>
        <pub-id pub-id-type="pmid">31181401</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>UniProt</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>UniProt: a worldwide hub of protein knowledge</article-title>
        <source>Nucleic Acids Res</source>
        <year>2019</year>
        <volume>47</volume>
        <issue>D1</issue>
        <fpage>D506</fpage>
        <lpage>D515</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky1049</pub-id>
        <pub-id pub-id-type="pmid">30395287</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Tokheim</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Gan</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>North</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>XS</given-names>
          </name>
          <name>
            <surname>Pandolfi</surname>
            <given-names>PP</given-names>
          </name>
          <name>
            <surname>Wei</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Genetic fusions favor tumorigenesis through degron loss in oncogenes</article-title>
        <source>Nat Commun</source>
        <year>2021</year>
        <volume>12</volume>
        <issue>1</issue>
        <fpage>6704</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-021-26871-y</pub-id>
        <?supplied-pmid 34795215?>
        <pub-id pub-id-type="pmid">34795215</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <mixed-citation publication-type="other">Vig J, Madani A, Varshney LR, Xiong C, Socher R, Rajani NF. Bertology meets biology: interpreting attention in protein language models. arXiv preprint arXiv:2006.15222. 2020.</mixed-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <mixed-citation publication-type="other">Rives A, Meier J, Sercu T, Goyal S, Lin Z, Liu J, et al. Biological structure and function emerge from scaling unsupervised learning to 250 million protein sequences. Proc Natl Acad Sci U S A. 2021;118(15):e2016239118.</mixed-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rao</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bhattacharya</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Duan</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Canny</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Abbeel</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>YS</given-names>
          </name>
        </person-group>
        <article-title>Evaluating protein transfer learning with TAPE</article-title>
        <source>Adv Neural Inf Proces Syst</source>
        <year>2019</year>
        <volume>32</volume>
        <fpage>9689</fpage>
        <lpage>9701</lpage>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Andreatta</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Alvarez</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Nielsen</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>GibbsCluster: unsupervised clustering and alignment of peptide sequences</article-title>
        <source>Nucleic Acids Res</source>
        <year>2017</year>
        <volume>45</volume>
        <issue>W1</issue>
        <fpage>W458</fpage>
        <lpage>W463</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx248</pub-id>
        <?supplied-pmid 28407089?>
        <pub-id pub-id-type="pmid">28407089</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Low</surname>
            <given-names>TY</given-names>
          </name>
          <name>
            <surname>Peng</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Magliozzi</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Mohammed</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Guardavaccaro</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Heck</surname>
            <given-names>AJ</given-names>
          </name>
        </person-group>
        <article-title>A systems-wide screen identifies substrates of the SCFbetaTrCP ubiquitin ligase</article-title>
        <source>Sci Signal</source>
        <year>2014</year>
        <volume>7</volume>
        <issue>356</issue>
        <fpage>rs8</fpage>
        <pub-id pub-id-type="doi">10.1126/scisignal.2005882</pub-id>
        <?supplied-pmid 25515538?>
        <pub-id pub-id-type="pmid">25515538</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Coyaud</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Mis</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Laurent</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Dunham</surname>
            <given-names>WH</given-names>
          </name>
          <name>
            <surname>Couzens</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Robitaille</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gingras</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Angers</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Raught</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>BioID-based identification of Skp Cullin F-box (SCF)beta-TrCP1/2 E3 ligase substrates</article-title>
        <source>Mol Cell Proteomics</source>
        <year>2015</year>
        <volume>14</volume>
        <issue>7</issue>
        <fpage>1781</fpage>
        <lpage>1795</lpage>
        <pub-id pub-id-type="doi">10.1074/mcp.M114.045658</pub-id>
        <?supplied-pmid 25900982?>
        <pub-id pub-id-type="pmid">25900982</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hornbeck</surname>
            <given-names>PV</given-names>
          </name>
          <name>
            <surname>Kornhauser</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Latham</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Murray</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Nandhikonda</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Nord</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Skrzypek</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Wheeler</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Gnad</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <article-title>15 years of PhosphoSitePlus(R): integrating post-translationally modified sites, disease variants and isoforms</article-title>
        <source>Nucleic Acids Res</source>
        <year>2019</year>
        <volume>47</volume>
        <issue>D1</issue>
        <fpage>D433</fpage>
        <lpage>D441</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky1159</pub-id>
        <?supplied-pmid 30445427?>
        <pub-id pub-id-type="pmid">30445427</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>KY</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>TY</given-names>
          </name>
          <name>
            <surname>Kao</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>CT</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>TH</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>WC</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>HD</given-names>
          </name>
        </person-group>
        <article-title>dbPTM in 2019: exploring disease association and cross-talk of post-translational modifications</article-title>
        <source>Nucleic Acids Res</source>
        <year>2019</year>
        <volume>47</volume>
        <issue>D1</issue>
        <fpage>D298</fpage>
        <lpage>D308</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky1074</pub-id>
        <?supplied-pmid 30418626?>
        <pub-id pub-id-type="pmid">30418626</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rechsteiner</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Rogers</surname>
            <given-names>SW</given-names>
          </name>
        </person-group>
        <article-title>PEST sequences and regulation by proteolysis</article-title>
        <source>Trends Biochem Sci</source>
        <year>1996</year>
        <volume>21</volume>
        <issue>7</issue>
        <fpage>267</fpage>
        <lpage>271</lpage>
        <pub-id pub-id-type="doi">10.1016/S0968-0004(96)10031-1</pub-id>
        <?supplied-pmid 8755249?>
        <pub-id pub-id-type="pmid">8755249</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Walsh</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Martin</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Di Domenico</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Tosatto</surname>
            <given-names>SC</given-names>
          </name>
        </person-group>
        <article-title>ESpritz: accurate and fast prediction of protein disorder</article-title>
        <source>Bioinformatics</source>
        <year>2012</year>
        <volume>28</volume>
        <issue>4</issue>
        <fpage>503</fpage>
        <lpage>509</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btr682</pub-id>
        <?supplied-pmid 22190692?>
        <pub-id pub-id-type="pmid">22190692</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Faraggi</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kloczkowski</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Accurate single-sequence prediction of solvent accessible surface area using local and global features</article-title>
        <source>Proteins</source>
        <year>2014</year>
        <volume>82</volume>
        <issue>11</issue>
        <fpage>3170</fpage>
        <lpage>3176</lpage>
        <pub-id pub-id-type="doi">10.1002/prot.24682</pub-id>
        <?supplied-pmid 25204636?>
        <pub-id pub-id-type="pmid">25204636</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ingham</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Gish</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Pawson</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>The Nedd4 family of E3 ubiquitin ligases: functional diversity within a common modular architecture</article-title>
        <source>Oncogene</source>
        <year>2004</year>
        <volume>23</volume>
        <issue>11</issue>
        <fpage>1972</fpage>
        <lpage>1984</lpage>
        <pub-id pub-id-type="doi">10.1038/sj.onc.1207436</pub-id>
        <?supplied-pmid 15021885?>
        <pub-id pub-id-type="pmid">15021885</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ingham</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Colwill</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Howard</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Dettwiler</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lim</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hersi</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Raaijmakers</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Gish</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Mbamalu</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>WW domains provide a platform for the assembly of multiprotein networks</article-title>
        <source>Mol Cell Biol</source>
        <year>2005</year>
        <volume>25</volume>
        <issue>16</issue>
        <fpage>7092</fpage>
        <lpage>7106</lpage>
        <pub-id pub-id-type="doi">10.1128/MCB.25.16.7092-7106.2005</pub-id>
        <?supplied-pmid 16055720?>
        <pub-id pub-id-type="pmid">16055720</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Theurillat</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Udeshi</surname>
            <given-names>ND</given-names>
          </name>
          <name>
            <surname>Errington</surname>
            <given-names>WJ</given-names>
          </name>
          <name>
            <surname>Svinkina</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Baca</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Pop</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wild</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Blattner</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Groner</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Rubin</surname>
            <given-names>MA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Prostate cancer. ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer</article-title>
        <source>Science</source>
        <year>2014</year>
        <volume>346</volume>
        <issue>6205</issue>
        <fpage>85</fpage>
        <lpage>89</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1250255</pub-id>
        <?supplied-pmid 25278611?>
        <pub-id pub-id-type="pmid">25278611</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mathieson</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Franken</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kosinski</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kurzawa</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Zinn</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Sweetman</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Poeckel</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Ratnu</surname>
            <given-names>VS</given-names>
          </name>
          <name>
            <surname>Schramm</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Becher</surname>
            <given-names>I</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Systematic analysis of protein turnover in primary cells</article-title>
        <source>Nat Commun</source>
        <year>2018</year>
        <volume>9</volume>
        <issue>1</issue>
        <fpage>689</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-018-03106-1</pub-id>
        <?supplied-pmid 29449567?>
        <pub-id pub-id-type="pmid">29449567</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <mixed-citation publication-type="other">Meszaros B, Hajdu-Soltesz B, Zeke A, Dosztanyi Z. Mutations of intrinsically disordered protein regions can drive cancer but lack therapeutic strategies. Biomolecules. 2021;11(3):381.</mixed-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bailey</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Tokheim</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Porta-Pardo</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Sengupta</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bertrand</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Weerasinghe</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Colaprico</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Wendl</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Reardon</surname>
            <given-names>B</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Comprehensive characterization of cancer driver genes and mutations</article-title>
        <source>Cell</source>
        <year>2018</year>
        <volume>173</volume>
        <issue>2</issue>
        <fpage>371</fpage>
        <lpage>385 e318</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2018.02.060</pub-id>
        <?supplied-pmid 29625053?>
        <pub-id pub-id-type="pmid">29625053</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ellrott</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Bailey</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Saksena</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Covington</surname>
            <given-names>KR</given-names>
          </name>
          <name>
            <surname>Kandoth</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Stewart</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Hess</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Chiotti</surname>
            <given-names>KE</given-names>
          </name>
          <name>
            <surname>McLellan</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines</article-title>
        <source>Cell Syst</source>
        <year>2018</year>
        <volume>6</volume>
        <issue>3</issue>
        <fpage>271</fpage>
        <lpage>281 e277</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cels.2018.03.002</pub-id>
        <?supplied-pmid 29596782?>
        <pub-id pub-id-type="pmid">29596782</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bindea</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Mlecnik</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Hackl</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Charoentong</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Tosolini</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kirilovsky</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Fridman</surname>
            <given-names>W-H</given-names>
          </name>
          <name>
            <surname>PagÃ¨s</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Trajanoski</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Galon</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks</article-title>
        <source>Bioinformatics (Oxford, England)</source>
        <year>2009</year>
        <volume>25</volume>
        <issue>8</issue>
        <fpage>1091</fpage>
        <lpage>1093</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btp101</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <mixed-citation publication-type="other">Li J, Cai Z, Vaites LP, Shen N, Mitchell DC, Huttlin EL, et al. Proteome-wide mapping of short-lived proteins in human cells. Mol Cell. 2021;81(22):4722â35.e5.</mixed-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yokoyama</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Herriges</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Verheyden</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>E3 ubiquitin ligase RFWD2 controls lung branching through protein-level regulation of ETV transcription factors</article-title>
        <source>Proc Natl Acad Sci U S A</source>
        <year>2016</year>
        <volume>113</volume>
        <issue>27</issue>
        <fpage>7557</fpage>
        <lpage>7562</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.1603310113</pub-id>
        <?supplied-pmid 27335464?>
        <pub-id pub-id-type="pmid">27335464</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>GagnÃ©</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Pic</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Isabelle</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Krietsch</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ethier</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Paquet</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Kelly</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Boutin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Moon</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Foster</surname>
            <given-names>LJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Quantitative proteomics profiling of the poly(ADP-ribose)-related response to genotoxic stress</article-title>
        <source>Nucleic Acids Res</source>
        <year>2012</year>
        <volume>40</volume>
        <issue>16</issue>
        <fpage>7788</fpage>
        <lpage>7805</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gks486</pub-id>
        <?supplied-pmid 22669911?>
        <pub-id pub-id-type="pmid">22669911</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhu</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Lei</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Ju</surname>
            <given-names>LG</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Shao</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wei</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>XD</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>SPOP-containing complex regulates SETD2 stability and H3K36me3-coupled alternative splicing</article-title>
        <source>Nucleic Acids Res</source>
        <year>2017</year>
        <volume>45</volume>
        <issue>1</issue>
        <fpage>92</fpage>
        <lpage>105</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkw814</pub-id>
        <?supplied-pmid 27614073?>
        <pub-id pub-id-type="pmid">27614073</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <mixed-citation publication-type="other">Fakiruddin KS, Lim MN, Nordin N, Rosli R, Zakaria Z, Abdullah S. Targeting of CD133+ cancer stem cells by mesenchymal stem cell expressing TRAIL reveals a prospective role of apoptotic gene regulation in non-small cell lung cancer. Cancers. 2019;11(9):1261.</mixed-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <mixed-citation publication-type="other">Huang YL, Zhang PF, Hou Z, Fu Q, Li MX, Huang DL, et al. Ubiquitome analysis reveals the involvement of lysine ubiquitination in the spermatogenesis process of adult buffalo (Bubalus bubalis) testis. Biosci Rep. 2020;40(6):BSR20193537.</mixed-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhao</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Katuwawala</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Oldfield</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Dunker</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Faraggi</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Gsponer</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kloczkowski</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Malhis</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Mirdita</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Obradovic</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>DescribePROT: database of amino acid-level protein structure and function predictions</article-title>
        <source>Nucleic Acids Res</source>
        <year>2020</year>
        <volume>49</volume>
        <issue>D1</issue>
        <fpage>D298</fpage>
        <lpage>D308</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa931</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Paladin</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Schaeffer</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gaudet</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Zahn-Zabal</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Michel</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Piovesan</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Tosatto</surname>
            <given-names>SCE</given-names>
          </name>
          <name>
            <surname>Bairoch</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>The Feature-Viewer: a visualization tool for positional annotations on a sequence</article-title>
        <source>Bioinformatics</source>
        <year>2020</year>
        <volume>36</volume>
        <issue>10</issue>
        <fpage>3244</fpage>
        <lpage>3245</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btaa055</pub-id>
        <?supplied-pmid 31985787?>
        <pub-id pub-id-type="pmid">31985787</pub-id>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bouchard</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Otero</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Scott</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Szulc</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Martin</surname>
            <given-names>EW</given-names>
          </name>
          <name>
            <surname>Sabri</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Granata</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Marzahn</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Lindorff-Larsen</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Salvatella</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Cancer mutations of the tumor suppressor SPOP disrupt the formation of active, phase-separated compartments</article-title>
        <source>Mol Cell</source>
        <year>2018</year>
        <volume>72</volume>
        <issue>1</issue>
        <fpage>19</fpage>
        <lpage>36 e18</lpage>
        <pub-id pub-id-type="doi">10.1016/j.molcel.2018.08.027</pub-id>
        <?supplied-pmid 30244836?>
        <pub-id pub-id-type="pmid">30244836</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Paiva</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Crews</surname>
            <given-names>CM</given-names>
          </name>
        </person-group>
        <article-title>Targeted protein degradation: elements of PROTAC design</article-title>
        <source>Curr Opin Chem Biol</source>
        <year>2019</year>
        <volume>50</volume>
        <fpage>111</fpage>
        <lpage>119</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cbpa.2019.02.022</pub-id>
        <?supplied-pmid 31004963?>
        <pub-id pub-id-type="pmid">31004963</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Oughtred</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Stark</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Breitkreutz</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Rust</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Boucher</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Kolas</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>O'Donnell</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Leung</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>McAdam</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The BioGRID interaction database: 2019 update</article-title>
        <source>Nucleic Acids Res</source>
        <year>2019</year>
        <volume>47</volume>
        <issue>D1</issue>
        <fpage>D529</fpage>
        <lpage>d541</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky1079</pub-id>
        <?supplied-pmid 30476227?>
        <pub-id pub-id-type="pmid">30476227</pub-id>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Han</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Yi</surname>
            <given-names>GS</given-names>
          </name>
        </person-group>
        <article-title>E3Net: a system for exploring E3-mediated regulatory networks of cellular functions</article-title>
        <source>Mol Cell Proteomics</source>
        <year>2012</year>
        <volume>11</volume>
        <issue>4</issue>
        <fpage>O111.014076</fpage>
        <pub-id pub-id-type="doi">10.1074/mcp.O111.014076</pub-id>
        <?supplied-pmid 22199232?>
        <pub-id pub-id-type="pmid">22199232</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <mixed-citation publication-type="other">Du Y, Xu N, Lu M, Li T. hUbiquitome: a database of experimentally verified ubiquitination cascades in humans. Database (Oxford). 2011;2011:bar055.</mixed-citation>
    </ref>
  </ref-list>
</back>
